Rdh10-mediated Retinoic Acid Signaling Regulates the Neural Crest Cell Microenvironment During ENS Formation

preprint OA: closed CC-BY-NC-ND-4.0
📄 Open PDF Full text JSON View at publisher

Abstract

The enteric nervous system (ENS) is formed from vagal neural crest cells (NCC), which generate most of the neurons and glia that regulate gastrointestinal function. Defects in the migration or differentiation of NCC in the gut can result in gastrointestinal disorders such as Hirschsprung disease (HSCR). Although mutations in many genes have been associated with the etiology of HSCR, a significant proportion of affected individuals have an undetermined genetic diagnosis. Therefore, it’s important to identify new genes, modifiers and environmental factors that regulate ENS development and disease. Rdh10 catalyzes the first oxidative step in the metabolism of vitamin A to its active metabolite, RA, and is therefore a central regulator of vitamin A metabolism and retinoic acid (RA) synthesis during embryogenesis. We discovered that retinol dehydrogenase 10 ( Rdh10 ) loss-of-function mouse embryos exhibit intestinal aganglionosis, characteristic of HSCR. Vagal NCC form and migrate in Rdh10 mutant embryos but fail to invade the foregut. Rdh10 is highly expressed in the mesenchyme surrounding the entrance to the foregut and is essential between E7.5-E9.5 for NCC invasion into the gut. Comparative RNA-sequencing revealed downregulation of the Ret-Gdnf-Gfrα1 gene signaling network in Rdh10 mutants, which is critical for vagal NCC chemotaxis. Furthermore, the composition of the extracellular matrix through which NCC migrate is also altered, in part by increased collagen deposition. Collectively this restricts NCC entry into the gut, demonstrating that Rdh10 -mediated vitamin A metabolism and RA signaling pleiotropically regulates the NCC microenvironment during ENS formation and in the pathogenesis of intestinal aganglionosis.
Full text 135,472 characters · extracted from oa-pdf · 11 sections · click to expand

Abstract

The enteric nervous system (ENS) is formed from vagal neural crest cells (NCC), which generate most of the neurons and glia that regulate gastrointestinal function. Defects in the migration or differentiation of NCC in the gut can result in gastrointestinal disorders such as Hirschsprung disease (HSCR). Although mutations in many genes have been associated with the etiology of HSCR, a significant proportion of affected individuals have an undetermined genetic diagnosis. Therefore, it’s important to identify new genes, modifiers and environmental factors that regulate ENS development and disease. Rdh10 catalyzes the first oxidative step in the metabolism of vitamin A to its active metabolite, RA, and is therefore a central regulator of vitamin A metabolism and retinoic acid (RA) synthesis during embryogenesis. We discovered that retinol dehydrogenase 10 (Rdh10) loss-of-function mouse embryos exhibit intestinal aganglionosis, characteristic of HSCR. Vagal NCC form and migrate in Rdh10 mutant embryos but fail to invade the foregut. Rdh10 is highly expressed in the mesenchyme surrounding the entrance to the foregut and is essential between E7.5-E9.5 for NCC invasion into the gut. Comparative RNA-sequencing revealed downregulation of the Ret-Gdnf-Gfrα1 gene signaling network in Rdh10 mutants, which is critical for vagal NCC chemotaxis. Furthermore, the composition of the extracellular matrix through which NCC migrate is also altered, in part by increased collagen deposition. Collectively this restricts NCC entry into the gut, demonstrating that Rdh10-mediated vitamin A metabolism and RA signaling pleiotropically regulates the NCC microenvironment during ENS formation and in the pathogenesis of intestinal aganglionosis. .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint

Introduction

The gastrointestinal tract is an endoderm derived organ system that functions to process foods and liquids via mechanical and chemical digestion, while also playing a major role in immune system recognition of, and in response to, introduced pathogens(1-6). Most functions of the gastrointestinal tract are governed by the enteric nervous system (ENS) which is derived from vagal neural crest cells (NCC). Beginning around embryonic day (E) 8.75-9.0 of mouse embryogenesis, these multipotent progenitor cells delaminate from the neuroepithelium at the axial level of somites 1-7, migrate ventrally through the adjacent mesoderm, and enter the foregut mesenchyme by E9.5. Once in the gut, NCC must proliferate, migrate and colonize the full length of the growing gastrointestinal tract, and differentiate into the neurons and glia that comprise the myenteric and submucosal plexi of the ENS. Defects in NCC development can result in the absence of enteric ganglion cells along variable portions of the gastrointestinal tract, disrupting gut function and peristalsis. This type of gastrointestinal disorder is termed Hirschsprung disease (HSCR)(7), and affects 1 in 5000 live births. Patients with HSCR typically present with an inability to pass stool, resulting in abdominal discomfort and distension. Currently, treatment involves surgical resection of the aganglionic bowel(8), but patients with total intestinal aganglionosis require intestinal transplantation. Cell-based therapies for enteric neuropathies such as HSCR have emerged as potential, future treatment options that may one day be used in place of surgical intervention with more favorable patient outcomes (9-14). However, one of the greatest challenges to the development of new preventative therapies for HSCR is its complex etiology, being both multi-genic and variably penetrant. Although mutations in the RET-GDNF-GFRα1 signaling pathway genes account for 15%-35% of sporadic HSCR and about 50% of familial cases(15), a significant proportion of affected individuals have no known genetic diagnosis. Therefore, additional genes, modifiers and environmental factors must play important roles in the etiology of Hirschsprung disease, so it remains important to identify and understand the signals and mechanisms that regulate vagal neural crest cell development(16, 17). To discover novel genes that play important roles in neural crest cell development in an unbiased manner, we performed a three generation forward genetic screen in mice via N-ethyl- N-nitrosourea (ENU) induced mutagenesis(18). From this screen we recovered a mouse mutant, termed trex, which exhibited craniofacial(19-21) and limb malformations(22). Subsequently, we identified a point mutation in retinol dehydrogenase 10 (Rdh10) underlying the etiology of the trex phenotype. Rdh10 catalyzes the first oxidation reaction in the metabolism of vitamin A to its active metabolite, retinoic acid (RA). More specifically, retinol binding protein 4 (RBP4) transports vitamin A (all trans-retinol) from hepatocyte storage into cells via the cell surface receptor Stra6, and therein RDH10 converts all-trans-retinol to all-trans-retinal(19, 23, 24). All- trans-retinal is then oxidized to RA by ALDH1A1, ALDH1A2 and ALDH1A3 (formerly RALDH1, RALDH2, RALDH3) (25-27). RA is an essential signaling molecule in embryonic development, and through its interaction with retinoic acid receptors (RARs) and retinoid receptors (RXRs), which bind as heterodimers to the promoters of developmental genes, RA controls gene transcriptional activity(28-31). Both excess and deficiency of vitamin A and RA can cause developmental malformations and therefore physiological levels must be precisely controlled. .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint Using an allelic series of Rdh10 mice, we investigated both spatial and temporal contributions of Rdh10-mediated vitamin A metabolism and RA signaling to vagal NCC development and ENS formation during gastrointestinal development. We discovered that Rdh10 is required in a paracrine fashion between E7.5-9.5 for NCC migration, entry and colonization of the gut, and that loss-of-function results in intestinal aganglionosis. Comparative RNA-sequencing revealed that Rdh10-mediated RA signaling positively regulates the Ret-Gdnf- Gfrα1 gene network, which is critical for chemotactic entry of vagal NCC into the foregut and their subsequent migration and differentiation. RA signaling also regulates extracellular matrix composition (ECM), and in Rdh10 mutants, we observed major changes such as increased collagen deposition, possibly in association with increased stiffness. Together with alterations in focal cell adhesion, this may collectively impede NCC migration and prevent their entry into the gut, demonstrating that Rdh10-mediated vitamin A metabolism and RA signaling pleiotropically regulate the NCC microenvironment during ENS formation. Rdh10 loss-of-function and vitamin A deficiency therefore represent genetic and non-genetic risk factors respectively, in the etiology, penetrance and severity of intestinal aganglionosis and possibly Hirschsprung disease. .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint

Results

Rdh10trex/trex embryos exhibit intestinal aganglionosis Rdh10trex/trex mutant embryos were recovered in an ENU mutagenesis screen designed to identify novel genes important for the development of neural crest cells and their derivatives(18). In characterizing the craniofacial and limb malformations (18, 19, 21, 32), we performed β-tubulin III (TUJ1) immunostaining to assay for neuronal differentiation (Figure 1A- D). E10.5 wild-type embryos exhibit extensive neuronal differentiation in the forebrain and midbrain with well-developed cranial and dorsal root ganglion peripheral nerve projections (Figure 1A). In contrast, Rdh10trex/trex embryos presented with hypoplastic forebrain and midbrain neural networks, abnormal cranial nerve patterning, and an absence of enteric neurons in the developing GI tract (Figure 1C). The absence of mature enteric neuronal differentiation is clearly apparent in isolated intestines from E11.5 Rdh10trex/trex embryos compared to controls (Figure 1B,D). This intestinal aganglionosis phenotype mirrors severe Hirschsprung Disease (HSCR) in humans, rendering Rdh10trex/trex embryos a potential new genetic model of this devastating condition. As a first step in understanding the mechanistic origins of the gastrointestinal defects in Rdh10 trex/trex embryos, we characterized the spatiotemporal activity of Rdh10 during normal embryogenesis (Figure 1E-N). We previously reported that Rdh10 expression is first detected at E8.0, in the neural groove of the prospective hindbrain and in the lateral mesoderm(19). Using Rdh10βgeo/+ mice where LacZ activity serves as a proxy for Rdh10 expression, we observed LacZ staining in the anterior somites and adjacent lateral mesoderm as well as in the mesenchyme surrounding the primitive gut at E8.5 (Figure 1E,F,I,L). The axial domain of staining corresponds to the vagal region from which enteric NCC are derived. The spatiotemporal expression of Rdh10 is developmentally dynamic as is evidenced by the pattern of LacZ staining in E9.5-10.5 embryos. Rdh10 is expressed in posterior somites in E9.5 embryos and continues to be expressed in the ventral mesoderm as well as the anterior foregut diverticulum mesenchyme (Figure 1G,J). A similar pattern of Rdh10 expression is observed via in situ hybridization (Figure 1M,N). In E10.5 Rdh10 βgeo/+ embryos, LacZ activity persists in the somites and ventral mesoderm, but has decreased considerably in the mesenchyme at the entrance to the foregut (Figure 1H,K). Interestingly, the spatiotemporal expression of Rdh10 encompasses the ventral migration route vagal neural crest cells traverse from the neural tube to the foregut, implying it could play a critical role in NCC migration or entry into the foregut and their subsequent formation of the ENS during gastrointestinal development. Vagal NCCs migrate ventrally but do not invade the foregut of Rdh10trex/trex embryos To determine whether perturbation of NCC migration and/or differentiation could account for intestinal aganglionosis in Rdh10trex/trex embryos, we examined the activity of Sox10 (Supplemental Figure 1A-D’), which is expressed by migrating NCC and is a master regulator of neuroglial differentiation. In E9.5 control embryos, Sox10 staining indicates NCC form and migrate ventrally into the anterior region of the foregut (Supplemental Figure 1A,A’). This differs considerably from Rdh10trex/trex mutant embryos in which Sox10+ NCC remain in closer .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint proximity to the neural tube, with diminished ventral migration that culminates in an absence of NCC within the foregut region (Supplemental Figure 1C,C’). By E10.5, a stream of Sox10+ cells extending caudally into the midgut is evident in the GI tract of control embryos (Supplemental Figure 1B,B’). In contrast, Rdh10trex/trex mutant embryos continue to exhibit a complete absence of vagal NCC in the foregut (Supplemental Figure 1D,D’). Although Sox10+ NCC are formed in Rdh10trex/trex embryos, their ventral migration is disrupted between E9.0-E10.5, and they fail to invade the foregut or colonize more caudal regions of the GI tract. To validate perturbation of NCC migration as the cellular mechanism underpinning the pathogenesis of intestinal aganglionosis in Rdh10trex/trex embryos, we labeled migrating NCC and their neuronal derivatives in vivo using the Mef2c-F10N-LacZ reporter mouse(19) (Figure 2A-L). LacZ staining of control embryos reveals that NCCs migrate ventrally and begin to invade the foregut mesenchyme by E9.5 (Figure 2A-C). In contrast, although neural crest cells migrate ventrally in Rdh10trex/trex mutant embryos, they remain distant from the foregut (Figure 2D-F). By E10.5, the differences in neural crest cell migration and invasion of the gut mesenchyme are profound. In control embryos, vagal NCC have clearly migrated into the foregut with colonization extending to the midgut (Figure 2G-I). However, in Rdh10trex/trex embryos, no NCC appear to have invaded the foregut mesenchyme and very few LacZ+ NCC reach the vicinity of the foregut (Figure 2J,K). This abnormal pattern of NCC migration and failure to invade the foregut are evident in embryo sections (Figure 2L). These data suggest that vagal NCC form and migrate ventrally through the adjacent mesoderm in Rdh10trex/trex embryos but fail to invade the foregut mesenchyme to colonize the gastrointestinal tract. Although Sox10 and Mef2c-F10N-LacZ label migrating NCC and their neuronal derivatives(19), it was important to perform NCC lineage tracing in control and mutant Rdh10trex/trex embryos to examine the possibility of a switch in cell fate. Wnt1-Cre;R26R was bred into Rdh10trex/trex embryos to label dorsal neuroepithelial cells which encompass premigratory NCC and their descendants (Figure 2M-P’). In E9.5 control embryos, LacZ labeled vagal NCC migrate ventrally and enter the foregut (Figure 2 M,M’). By E10.5, LacZ labelled NCC form a clear caudally migrating stream in the GI tract extending from the foregut towards the midgut (black arrow in Figure 2O,O’). In contrast, although NCC migrate ventrally in E9.5 Rdh10trex/trex embryos, the extent of migration is considerably diminished compared to controls and NCC do not enter the foregut region (Figure 2N,N’). By E10.5, the confirmed absence of a caudally migrating stream of LacZ labelled cells in the gastrointestinal tract is indicative of the failure of NCC colonize the foregut in Rdh10 trex/trex embryos (Figure 2P,P’). Sox10 expression in combination with Mef2c-F10N-LacZ and Wnt1-Cre;R26R labeling collectively suggests that intestinal aganglionosis in Rdh10trex/trex embryos is due to the failure of NCC to migrate into the foregut. T o assess for NCC viability we performed immunostaining with Caspase-3 to label apoptotic cells in Rdh10trex/trex and control embryos (Supplemental Figure 2A-F’). Although we observed a small amount of cell death in the mesenchyme in close proximity to the foregut in Rdh10trex/trex embryos compared to controls (Supplemental Figure 2C-D’), it did not coincide with Ap2α+ labeled neural crest cells (Supplemental Figure 2E-F’). Interestingly, Rdh10 is .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint expressed in the mesenchyme adjacent to the foregut in E9.5 embryos (Figure 1M,N) correlating with the path NCC traverse to enter the foregut. These findings support altered migration as the basis for the absence of vagal NCC in the foregut of Rdh10trex/trex and implies that Rdh10-mediated RA signaling plays a paracrine or extrinsic role in the microenvironment of vagal NCC, facilitating their invasion and colonization of the foregut. Rdh10trex/trex mice display defects in retinoic acid signaling We previously reported that Rdh10 functions as a nodal point in vitamin A metabolism and the synthesis of RA during early embryogenesis (19, 20, 32). The trex mutation renders the enzymatic dehydrogenase/reductase activity of Rdh10 null and incapable of oxidizing vitamin A (retinol) to retinal(19). Therefore, we hypothesized that the perturbation of neural crest cell migration and the pathogenesis of intestinal aganglionosis in Rdh10trex/trex embryos was associated with diminished RA signaling. RARE-LacZ was then bred into Rdh10trex/trex embryos to visualize RA signaling via LacZ staining (Figure 3A-D)(19). In E8.5 wild-type embryos RA signaling is broadly active in the neuroepithelium and adjacent ventral mesenchyme from the axial level of the hindbrain extending posteriorly nearly all the way to the tail(19).. In E8.5 wild-type embryos RA signaling is broadly active in the neuroepithelium and adjacent ventral mesenchyme from the axial level of the hindbrain extending posteriorly nearly all the way to the tail(33). By E9.5 RA signaling has become active in the forebrain, while the previous anterior limit of RARE-LacZ activity has receded to the hindbrain/spinal cord junction with signaling now extending into the tail (Figure 3A). In contrast, Rdh10 trex/trex embryos exhibit a complete absence of RA signaling prior to E8.75 (10 somite stage)(19, 33, 34). E9.5 Rdh10trex/trex embryos display limited RA activity, which is confined to the ventral neural tube , and is absent from the adjacent ventral mesenchyme (Figure 3C). Of note, the developing cranium is nearly absent of RA signal at E9.5 in Rdh10trex/trex; RARE-LacZ embryos yet cranial neural crest cells have successfully migrated to distal branchial arches in the Rdh10trex/trex embryos (18, 32). Retinoic acid signal can be contrasted to the Rdh1 0 spatiotemporal expression between E8.5 -10.5 shown by LacZ staining of the Rdh10 βgeo mouse line (Figure 1E-L). Rdh10 expression is a smaller subset of active signal in the neural tube-somite- mesenchyme axis as compared to RARE-lacZ. Diminished RA signaling in Rdh10trex/trex embryos is particularly evident in the gastrointestinal tract. In guts isolated from E12.5 control embryos, RARE-LacZ activity detected throughout the stomach and intestine extending distally to the cecum (Figure 3B). In contrast, in E12.5 Rdh10trex/trex guts, the domain of RA signaling is considerably reduced in the hypoplastic stomach, and is diminished in the small intestine (Figure 3D). Collectively, these data suggest that Rdh10 loss-of-function results in reduced RA signaling in vagal level mesoderm and foregut mesenchyme, which spatiotemporally correlate s with the perturbation of NCC migration and entry into the foregut. Rdh10trex/trex intestinal aganglionosis is not caused by delayed NCC migration Rdh10trex/trex embryos typically die between E12.5-14.5, due to cardiovascular failure and hemorrhage. To bypass this lethality and evaluate NCC migration defects as a cause of intestinal aganglionosis, we isolated GI tracts from E11.5 control and Rdh10trex/trex embryos and cultured themin retinoid-deficient media for 2, 4 or 10 days (Supplemental Figure 3A-H). E11.5 control .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint embryos have mature neurons in the primitive GI tract extending from the foregut to the cecum between the midgut and hindgut as evidenced by TUJ1 staining. In contrast, the GI tract in Rdh10trex/trex embryos exhibits neuronal agenesis (Figure 1 B, D; Supplemental Figure 3 A, E). In controls, after 2 days of culture, NCC have colonized the hindgut and begun to form a dense neural network. After 4 days and continuing to 10 days of culture, the intestines in control embryos exhibit a thick, reticulated neural network extending into the hindgut (Supplemental Figure 3B-D). In contrast, the intestines of Rdh10trex/trex embryos exhibit little to no neuronal staining (Supplemental Figure 3F,G,H) irrespective of the length of time they were cultured. These in vitro culture experiments suggest that the gut phenotype observed in E11.5 Rdh10trex/trex embryos is not due to delayed vagal NCC migration or defects in their survival, but rather a failure of NCC to enter the foregut in association with perturbed Rdh10-mediated RA signaling. To further substantiate a requirement for RA signaling in NCC entry and colonization of the GI tract, we examined a second retinoid signaling deficient mouse line, Aldh1a2gri/gri, which we also recovered in our ENU mutagenesis screen(18). Aldh1a2 functions in the second step of vitamin A metabolism, oxidizing retinal to retinoic acid and we previously showed Aldh1a2gri/gri embryos exhibit a near total absence of RARE-LacZ activity, consistent with a loss of RA signaling(19). Aldh1a2gri/gri embryos survive until approximately E10.0 and Sox10 labeling of NCC revealed abnormal patterns of cranial and trunk NCC, including defective ventral migration of vagal NCC. The NCC in Aldh1a2gri/gri mutant embryos also fail to enter and colonize the GI tract in contrast to littermate controls (Supplemental Figure 3I-J’). Taken together with the phenotype of Rdh10trex/trex embryos, our data reveals that RA signaling is essential for vagal NCC invasion and colonization of the foregut. Rdh10-mediated retinoid signaling is required prior to E11.5 for NCC migration, entry, and colonization of the GI tract during ENS development. The association between the spatiotemporal activity of Rdh10 and RA signaling during the migration and entry of vagal NCC into the foregut raised the possibility that the intestinal aganglionosis phenotype in Rdh10 trex/trex embryos could be rescued via retinoid supplementation. Consistent with this idea, previous work has suggested that RA signaling promotes NCC migration throughout the GI tract(18). Therefore, we tested whether retinoid supplementation could rescue the migration of vagal NCC and their entry into the foregut and subsequently facilitate enteric neuron differentiation and ENS formation in Rdh10 trex/trex embryos. Intestines isolated from E11.5 control and Rdh10trex/trex embryos were cultured with either all-trans-retinoic acid or retinal for 4 days each (Supplemental Figure 4A-F). Compared to untreated controls, wild-type GI tracts cultured with 25nM of all-trans-RA, a sub-physiological, non-teratogenic dose(22), continued to display thick, reticulated neural networks, as evidenced by TUJ1 immunostaining (Supplemental Figure 4A,B). In contrast, cultured Rdh10trex/trex intestines remain largely devoid of TUJ1 immunostaining indicative of persistent intestinal aganglionosis (Supplemental Figure 4D,E). All-trans-RA has the potential to cause teratogenic defects(18), therefore, to ensure a more relevant physiological effect, we supplemented cultured control and mutant GI tracts with 0.3nM(18) retinal since retinal will only be converted to RA in an appropriate temporal and tissue specific manner by Aldh1a2 (Raldh2). Control GI tracts that were supplemented with retinal exhibited neural networks throughout the gut but .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint were grossly less complex than in control untreated cultured intestines (Supplemental Figure 4A,C). In contrast, Rdh10trex/trex GI tracts remained aganglionic (Supplemental Figure 4F). Thus, culturing E11.5 Rdh10trex/trex gastrointestinal tracts for 4 days with either retinal or RA provides no improvement in colonization or neuronal differentiation. The results of our in vitro GI tract organ culture experiments confirm the absence of NCC from the foregut in Rdh10trex/trex embryos, and suggest retinoid signaling is required prior to E11.5 for proper NCC migration, entry and colonization of the GI tract, during ENS development. Rdh10trex intestinal aganglionosis can be rescued by in utero dietary retinal supplementation To refine the temporal window during which retinoid signaling is required for NCC migration and ENS formation, we mated Rdh10trex/+ mice together, and supplemented pregnant dams with retinal (12.5mg all-trans-retinal/kg maternal body weight) via oral gavage once per day from E7.5-E11.5 (Figure 4 A,B,D,E). Wild-type and mutant embryo GI tracts were subsequently harvested at E11.5 for analysis. Once daily retinal gavage of control embryos from E7.5- E11.5 revealed typical enteric neuron development with an extensive network throughout the stomach and intestine extending toward the cecum which was comparable to untreated controls (Figure 4 A,B). Unlike the aganglionic phenotype in untreated Rdh10trex/trex embryos (Figure 4D) retinal treated Rdh10trex/trex embryos developed mature neurons in the foregut and intestine, extending towards the cecum (Figure 4E). These data suggest retinoid signaling is required prior to E11.5 for NCC entry, colonization and differentiation in the GI tract. To increase retinal availability in Rdh10trex/trex embryos, we performed twice daily supplementation with retinal on consecutive days beginning at E7.5. Embryos were harvested at E11.5. Compared with once daily retinal supplementation, twice daily supplementation between E7.5-E9.5, resulted in a phenotypic rescue of ENS formation in Rdh10trex/trex embryos by E11.5. Neuronal differentiation in Rdh10trex/trex GI tracts was comparable to treated and untreated control GI tracts, with mature neurons in the stomach and intestines, extending to the cecum (Figure 4 A,C,F). Collectively these results demonstrate Rdh10 mediated RA signaling is required from E7.5 to E9.5 for proper ENS formation. This period immediately precedes vagal NCC entry into the foregut and colonization of the GI tract. These maternal gavage data imply that Rdh10 is not required for the maintenance of NCC migration or colonization once NCC are already in the GI tract. Rather, Rdh10-mediated RA signaling is essential for vagal NCC migration and entry into the foregut. Consistent with these observations, we previously showed that retinal supplementation can rescue Rdh10trex/trex embryos through to birth with postnatal survival (22). Temporal deletion of Rdh10 in Rdh10flox/flox; ERT2Cre mice confirms early requirement of retinoids during ENS development To corroborate the spatiotemporal requirement for Rdh10-mediated RA signaling in ENS formation, we generated Rdh10flox/flox mice, which were crossed to a Tamoxifen inducible ubiquitous Cre line, ERT2Cre(18), which allows for the selective temporal excision of Rdh10, simultaneously overcoming the limitations of Rdh10trex/trex embryo lethality and the need for retinoid supplementation. Tamoxifen (5mg) and progesterone (1mg) were co-administered to pregnant dams via oral gavage at a single time point between E6.5 to E11.5. .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint Rdh10flox/flox;ERT2Cre embryos were subsequently harvested at E15.5 and assessed for NCC colonization of the gut and ENS differentiation (Figure 4G-R). Temporal excision of Rdh10 by E7.5, following Tamoxifen administration to Rdh10flox/flox; ERT2Cre embryos at E6.5, results in intestinal aganglionosis throughout the duodenum, cecum and distal colon (Figure 4J-L). In contrast, administration of Tamoxifen to Rdh10flox/flox; ERT2Cre embryos at E7.5 with subsequent deletion by E8.5 results in enteric neuron differentiation in the duodenum and cecum, but distal colonic aganglionosis, reminiscent of a short-segment Hirschsprung disease phenotype (Figure 4M-O). Temporal removal of Rdh10 at later time points (E9.5 - E11.5) does not induce a HSCR-like phenotype (Figure 4P-R and data not shown). Normal gut colonization and ENS formation was observed in all treated Rdh10flox/+ littermates irrespective of the age of treatment (E10.5 gavage shown Figure 4G-I). These conditional deletion studies further define the precise temporal requirement for Rdh10-mediated RA production and augments the data obtained from retinal-supplemented in vivo cultures of Rdh10trex/trex GI tracts. Rdh10-mediated RA signaling is therefore required between E7.5-9.5 during which vagal NCC are born, migrate ventrally and invade the foregut. In contrast, Rdh10 appears not necessary for the maintenance of NCC migration and colonization of the GI tract after NCC have entered the foregut. Non-cell autonomous paracrine effect of Rdh10-mediated RA signaling on NCC The early temporal requirement for Rdh10-mediated RA signaling to form a complete enteric nervous system raised the question of whether Rdh10 is cell autonomously and intrinsically required in NCCs, or whether it functions non-cell autonomously in a paracrine fashion within the NCC microenvironment. To test for an intrinsic cell autonomous role in NCC, we conditionally deleted Rdh10 in the dorsal neuroepithelium, the territory from which NCCs are derived using Wnt1Cre. E10.5 Rdh10flox/flox;Wnt1Cre and Rdh10flox/flox whole embryos exhibit normal peripheral nervous system development with clear neuronal labeling in the anterior GI tract (Supplemental Figure 5A,B). Whole GI tracts isolated from E18.5 Rdh10flox/flox as well as Rdh10flox/flox;Wnt1Cre embryos displayed a similar gross neuronal network and density along the entire length of the GI tract (Supplemental Figure 5C-H). Furthermore, Rdh10flox/flox;Wnt1Cre mice are viable postnatally and do not exhibit any obvious motility or gastrointestinal dysfunction as measured by carmine red whole gut transit assay. Because vagal nerve development and ENS formation were unaffected in NCC-specific conditional knockouts of Rdh10, Rdh10 is therefore not intrinsically or cell autonomously required in vagal NCC for their migration and entry into the foregut, nor for their migration throughout the GI tract, or differentiation, during formation of the ENS. Targeted qRT-PCR and in situ hybridization reveal disruptions in Ret signaling axis in Rdh10 trex/trex embryos Mutations in the RET-GDNF-GFRA1 signaling axis genes are principally associated with the etiology of HSCR. Interestingly, loss-of-function mouse models of each gene exhibit intestinal aganglionosis(35, 36), similar to the phenotype described above in Rdh10trex/trex embryos. Ret and Gfrα1 are co-receptors for Gdnf, and each play important roles in promoting NCC migration(37, 38) and ENS formation. Ret is expressed by migrating vagal neural crest cells .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint and its expression is maintained throughout colonization of the gut(39). Similarly, Gfrα1 is also expressed by NCC. Gdnf however, is expressed primarily in the mesenchyme where it functions in a paracrine manner as a chemoattractant for NCC to invade the foregut. We used qRT-PCR and in situ hybridization to assess Rdh10 mediated regulation of this pathway by comparing the levels and spatial domains of gene expression. qRT-PCR revealed that the levels of Ret, Gdnf and Gfrα1 mRNA in E9.5 Rdh10trex/trex embryos were significantly reduced to 54%, 70% and 49% (p<0.05), respectively of wild-type levels (Figure 5A). We verified the decrease in Ret and Gdnf expression by in situ hybridization (Figure 5 B-I). In E9.5 control embryos, Ret expression was evident within the foregut extending caudally to the midgut (Figure 5 B,B’). In contrast, there was a complete absence of Ret labeled cells in the developing gut of Rdh10trex/trex mutant embryos (Figure 5 C,C’). To evaluate if a disruption in ligand signaling underlies the mutant phenotype, we evaluated the activity of the Ret ligand, Gdnf, which is normally expressed within the foregut mesenchyme through which vagal neural crest cells migrate in E9.25-9.5 wildtype embryos (Figure 5 D, D’, F, F’). We found that Gdnf expression was decreased in Rdh10trex/trex mutant embryos (Figure 5 E,E’G,G’). Sections of E9.5 control embryos highlight the expression of Gdnf within the foregut mesenchyme and epithelium (Figure 5 H,H’). In contrast, Rdh10trex/trex embryos exhibit reduced levels of Gdnf in the foregut mesenchyme and epithelium (Figure 5 I, I’), consistent with the qRT-PCR results (Figure 5 A). To further evaluate if there was an association between RA signaling and Gdnf activity, we examined the expression of Gdnf in E9.5 Aldh1a2gri/gri embryos, which we previously showed were deficient in RA signaling(19) similar to Rdh10trex/trex embryos. E9.5 control embryos display Gdnf expression within the foregut (Supplemental Figure 6 A,A’, C, C’). In contrast, Aldh1a2gri/gri embryos exhibit diminished Gdnf activity within the foregut region (Supplemental Figure 6 B,B’, D, D’). The downregulation of Gdnf expression in Aldh1a2gri/gri embryos is consistent with our

Results

in Rdh10trex/trex embryos and substantiates a role for RA signaling in regulating Gdnf expression during NCC entry into the foregut. Since Rdh10 is not intrinsically required in vagal NCC, our qRT-PCR and expression analyses in Rdh10trex/trex and expression data in Aldh1a2gri/gri embryos indicate that Rdh10 operates in a paracrine fashion to promote vagal NCC migration and entry into the foregut in part by functioning upstream of Ret-Gdnf-Gfrα1 signaling. RNA sequencing reveals alterations in ENS development genes in Rdh10trex/trex embryos Our data indicates that RA signaling plays a critical role in regulating the NCC microenvironment. To gain a deeper understanding of the impact of RA signaling, we performed comparative transcriptomics analyses via bulk RNA-sequencing of the vagal region in E9.5 control and Rdh10trex/trex littermate embryos. RNA sequencing identified 20,883 genes that were then analyzed by EdgeR, which revealed 4,366 genes that were differentially regulated between Rdh10 trex/trex and control embryos with a p-value < 0.05. Of these genes, 1,095 were changed by at least 1.74-fold with a p-value < 0.05, including 533 upregulated and 562 downregulated genes (Figure 6). With this gene set, we used targeted analysis to identify genes that have a known role in ENS development and HSCR etiology, as well as an unbiased approach using enrichment analysis to uncover critical genes and pathways that are regulated by RA signaling during ENS formation. .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint First, we used a targeted analytical approach to identify genes that had ≥ 2-fold expression change with a p-value < 0.05, and that when mutated were already known to produce an overt intestinal phenotype in mouse models. Gfra1, Phox2b and Ecel1 were downregulated, whereas Col6a4 was upregulated in Rdh10trex/trex embryos compared to controls (Supplemental Table 1). Gfrα1 is a receptor for Gdnf and therefore a major regulator of the Ret- Gdnf-Gfrα1 signaling axis as is Phox2b, which can specifically regulate Ret expression(40). Phox2b downregulation was validated using immunohistochemistry (Figure 7 A-G). Gfrα1 and Phox2b loss-of-function mouse mutants exhibit intestinal aganglionosis(41-43), whereas Ecel1 mutants present with distal colonic aganglionosis(44), consistent with each of these genes functioning in vagal NCC migration and ENS formation(43, 44). Furthermore, mutations in GFRA1, PHOX2B and ECEL1 have all been identified in patients with HSCR(45-47). The same is also true for PAX3 and EDNRB, and loss-of-function mouse models exhibit total (Pax3) or distal (Ednrb) intestinal aganglionosis. Both Pax3 and Ednrb were also downregulated in Rdh10trex/trex embryos compared to controls. In addition, we noted downregulation of specific genes known to regulate Ret expression such as Rarβ, Hoxb5 and Nkx2.1(40, 48) (p-value < 0.05) (Supplemental Table 1). RARβ is a receptor for RA, is expressed in NCC, and binds to enhancer regions of Ret to promote its activity(49). Hoxb5 is expressed in vagal NCC and functions in ENS formation as Hoxb5 mouse mutants exhibit hypoganglionosis(50). Hoxb5 also forms a complex with Nkx2.1 to synergistically regulate Ret, as well as coordinate with Phox2b and Pax3 to mediate expression at the Ret promoter(40, 50). In addition to Hoxb5, we identified several other Hox genes that were also differentially expressed by over 2-fold with a p-value < 0.05 (Supplemental Table 1). This is consistent with Hox gene activation by RA during anterior- posterior patterning of the gut and their association with ENS formation and HSCR pathogenesis (51-53). In contrast to downregulation of the genes noted above, others such as, Col6a4, were upregulated in Rdh10trex/trex embryos (Supplemental Table 1). Collagen VI immunostaining appeared increased in Rdh10trex/trex , but was not statistically significant when quantified as fluorescent intensity (Figure 8 E-H, L), However, Col6α4 is expressed in the extracellular matrix of the developing gut and known to negatively regulate NCC migration(54). In fact, increased Col6a4 production can cause distal colonic aganglionosis in mouse models(54) and patients with HSCR have been diagnosed with abnormally high levels of Collagen VI surrounding the myenteric plexus(54). The misregulation of genes involved in ENS development, Ret signaling and the etiology of HSCR demonstrate that Rdh10 mediated RA signaling regulates a diverse genetic network that is instrumental in promoting vagal NCC development during ENS formation and in the pathogenesis of HSCR (Figure 7H). RNA sequencing reveals significant alterations in extracellular matrix prote ins and focal adhesion proteins in Rdh10trex/trex embryos We utilized RNA sequencing enrichment analyses to identify gene and pathway changes in an unbiased manner. The relationship between gene expression ratio (trex/wt) and signal strength is displayed in the MA plot. Genes with p-values less than 0.01 and a fold change greater than 1.74-fold are highlighted in color (Figure 6A). The top up and down regulated genes were examined for enrichment of gene ontology (GO) terms. This identified enrichment .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint in several biological processes related to cellular responses to oxygen levels, decreased oxygen levels and hypoxia (Figure 6B). Elevated hypoxia is associated with defects in vasculogenesis(55). This is notable as RA regulates endothelial cells during vascular modeling and patterning(56). Retinoid deficient models of Raldh2 have defects in vasculogenesis in the yolk sac(56) and cranial vascular plexi(18). Similarly, Rdh10trex/trex embryos display defective vasculogenesis as evidenced by a diminished dorsal aorta(18) and hemorrhaging that likely contributes to embryo lethality(19). In addition to these biological processes, we identified enrichment in the cellular components of interstitial and extracellular matrix, and extracellular space (Figure 6 B). Interestingly, the interstitial matrix is a specific type of extracellular matrix found in interstitial connective tissue, characterized by the presence of fibronectins, and types I, III, V, VI, VII and XII collagens, many of which were upregulated in Rdh10trex/trex embryos (Figure 6, Supplemental Table 2). Fibronectin is localized to the extracellular matrix and promotes NCC migration(57-60), in addition to binding other components of the interstitial and extracellular matrix, including collagens(60-62). However, Collagen VI can impede fibronectin’s positive affect on NCC migration(54, 63), illustrating the importance of matrix composition and its effects. In addition to GO analysis, we performed Signaling Pathway Impact Analysis (SPIA)(64) to assess Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway perturbations on all genes with an adjusted p-value of 0.05 or less. This returned 1992 genes, of which 1851 mapped to Entrez IDs. We noted an enrichment in ECM-receptor interaction and focal adhesion pathways in Rdh10 trex/trex embryos (Figure 6B), which are also known to affect NCC migration. To validate the findings using SPIA, we employed additional pathway enrichment programs, such as ToppGene and DAVID, which consistently revealed enrichment in matrix and adhesion. Some of these pathways included ECM organization and interactions, focal adhesion, and collagen biosynthesis (Supplemental Table 2). Analysis by ToppGene also identified enrichment in Hif1α signaling, which was the top pathway identified by SPIA (Figure 6C; Supplemental Table 2). We noted GO term enrichment in several biological processes related to hypoxia, and Hif1α is a hypoxia-inducible factor that regulates signaling targets in low oxygen conditions. The pathways identified by SPIA, DAVID and ToppGene for ECM receptor interaction and focal adhesion, also align with our GO analysis as many of their gene products localize to the interstitial and extracellular matrix, and space. Additionally, receptor ligand activity identified by GO analysis corresponds in molecular function to many of the genes in the ECM receptor interaction pathway (Figure 6; Supplemental Table 2). To identify gene changes related to ECM receptor interaction and focal adhesion, we utilized Ingenuity Pathway Analysis (IPA) which identified 128 differentially regulated genes (p- value ≤ 0.05) associated with ECM organization, binding, or adhesion, including several known to affect NCC migration (Supplemental Table 3). For example, the adhesion molecule L1cam, which was downregulated, promotes chain migration of NCC and is a modifier of ENS formation(65, 66). In contrast, Laminin B1, which was increased, is inhibitory to NCC migration in the gut(67). Furthermore, there was a sizeable upregulation in numerous distinct collagens which aligned with GO term enrichment in collagen-containing interstitial and extracellular .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint matrix (Figure 6A) as well as DAVID pathway analysis enrichment in collagen biosynthesis and modifying enzymes (Supplemental Table 2). We validated the increase in collagen using both qRT-PCR and Sirius red staining (Figure 8). qRT-PCR confirmed that both Col1a1 and Col1a2 were significantly upregulated in Rdh10trex/trex with a p-value < 0.05 (Figure 8 A). The regulation of collagen by RA is not well understood, however RA is known to directly regulate the Col1a1 gene(68), as well as Col1a2 through direct binding of its promoter by Rarβ(69, 70). Picro-Sirius red dyes specifically label components of collagen(71), and we used Sirius red staining to evaluate global alterations in collagen composition in the extracellular matrix. In comparison to Sirius red stained sections of E9.5 wild-type embryos, we observed a significant (p<0.05) increase in collagen throughout the foregut of Rdh10 trex/trex embryos (Figure 8 A-D’). Greater than 50% increase was quantified by measuring the fluorescent intensity of Sirius red staining within a defined region of the anterior foregut mesenchyme which coincides with the entry of neural crest cells into the gastrointestinal tract (Figure 8 B’, D’, I-K). The upregulation of collagen was notable as individual components of collagen such as, Col6a4(54), as well as collectively high levels of collagen in the gut can reduce NCC migration resulting in abnormal intestinal development(72). Increased collagen composition in the extracellular matrix has previously been associated with increased stiffness and the inhibition of cell migration(54). Therefore, the increase in collagen deposition may increase matrix stiffness in the anterior foregut mesenchyme in Rdh10 trex/trex embryos, which in turn impedes NCC migration. In concert with decreased Ret-GDNF-GFRa1 signaling, this could restrict the entry of vagal NCC into the foregut, resulting in their failure to colonize the gastrointestinal tract and form the ENS.

Discussion

Rdh10 and RA signaling are required prior to vagal NCC invasion of the foregut during ENS formation Retinoic acid (RA) has been implicated as an important morphogen in ENS development(73-76) and is temporally required for enteric neural crest cell chain migration into the foregut(77). Most mammalian models of RA deficiency however required dietary modification to reveal an intestinal phenotype. For example, mice with genetic deletion of RBP exhibit low retinol concentrations in their circulation(78) and give birth to viable offspring(79) . Only when challenged with dietary vitamin A deprivation do Rbp4-/- mutant mice elicit distal colonic aganglionosis(75).. Conversely, Raldh2-/- mutant embryos are lethal around E8.5 prior to ENS formation(26), but if maternally supplemented with RA, they survive long enough to present with intestinal aganglionosis and other developmental anomalies(80). Although in vitro and in vivo studies revealed a link between Rbp4 and Raldh2 (Aldh1a2)(75, 76, 80-82), the manifestation of an intestinal phenotype only occurred in association with dietary modification, leaving unresolved the spatiotemporal requirement and function of RA during NCC invasion and colonization of the gut. A recent study defined cell-autonomous roles for the RA receptor α (RARα) using numerous Cre-drivers and found that when activating the dominant negative RarαDN in premigratory and migratory stages, mice develop intestinal aganglionosis, but conditional deletion at later stages result in much milder phenotype(83). In human HSCR bowel .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint tissue, RARα and its coregulator CREB-binding protein (CBP) were expressed in ganglionated bowel segments but were reduced in aganglionic segments(84). We discovered that Rdh10trex/trex embryos, which are RA signaling deficient, survive until E13.5-14.5, and present with intestinal aganglionosis. This characteristic makes Rdh10trex/trex embryos a useful genetic model to study the effects of vitamin A metabolism on vagal NCC development and ENS formation. Using an allelic series of Rdh10 mice, we determined that Rdh10-mediated RA signaling is required in a paracrine fashion between E7.5-9.5 for vagal NCC invasion of the foregut. This early requirement was revealed by deleting Rdh10 in a temporal manner throughout the embryo with ERT2Cre. Excision between E7.5-9.5 resulted in intestinal aganglionosis (Figure 4). In contrast, excision after E9.5 did not impact ENS formation, indicating that once NCC are within the foregut, Rdh10 does not appear to be required for their continued migration and, or differentiation throughout the rest of the GI tract. Consistent with this idea, twice daily gavage with retinal between E7.5 to E9.5 was sufficient to rescue intestinal aganglionosis in Rdh10trex/trex embryos (Figure 4). Our studies therefore in combination with prior work in zebrafish, xenopus, avian, mice and humans suggests a conserved requirement for RA signaling in ENS development. Rdh10 and RA signaling are required to facilitate vagal NCC migration into the foregut entrance HSCR associated intestinal aganglionosis has previously been attributed to perturbed NCC migration or differentiation throughout the gut (85, 86). Therefore, to assess the mechanistic role of Rdh10-mediated RA signaling, we indelibly labeled NCC and their descendants in Rdh10trex/trex embryos and observed that they fail to invade the foregut (Figure 2). Interestingly, Rdh10 is highly expressed in the mesenchyme through which the vagal NCC migrate (Figure 1) and RA signaling is diminished in this territory in Rdh10trex/trex embryos. We did not observe apoptosis specific to the vagal NCC population (Supplemental Figure 2), nor did we observe gastrointestinal defects when Rdh10 was conditionally deleted in neural crest cells (Supplemental Figure 5). Thus, the inability of vagal NCC to migrate into the foregut in Rdh10trex/trex embryos points to a role for Rdh10-mediated RA signaling as a paracrine factor in the NCC microenvironment. In further support of this idea, we showed that Aldh1a2gri/gri embryos which are also deficient in RA signaling, exhibit a similar failure in NCC invasion of the foregut (Supplemental Figure 3). Therefore, Rdh10-mediated spatiotemporal RA signaling facilitates vagal NCC invasion of the foregut, which is a critical step in NCC migration and colonization of the GI tract during ENS formation. ENCC developmental and microenvironment genes are altered in Rdh10trex/trex embryos Mutations in RET, GDNF and GFRA1 are principally associated with the etiology of HSCR, of which variable intestinal aganglionosis is a defining feature (87),(88). In fact, approximately 63% of individuals with HSCR possess mutations in the RET signaling gene network which result in an overall decrease in RET signaling(88). Ret and its co-receptor Gfrα1 are expressed on the surface of vagal NCC, whereas their ligand, Gdnf, is expressed in the mesenchymal .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint microenvironment through which vagal NCC migrate. This creates a ligand-receptor gradient important for the chemotactic entry of vagal NCC into the foregut around E9.5(37), and then again during their continued migration and colonization of the GI tract. Ret, Gdnf and Gfra1 null mouse mutants therefore each exhibit intestinal aganglionosis(39, 42, 43, 89-91), and we discovered that expression of the Ret signaling network is downregulated in Rdh10trex/trex embryos consistent with the pathogenesis of intestinal aganglionosis in Rdh10trex/trex embryos. More specifically, Ret expression was absent in E9.5 Rdh10trex/trex embryos and Gdnf expression was considerably diminished (Figure 5). Furthermore, Gdnf expression was also affected in RA signaling deficient Aldh1a2gri/gri embryos (Supplemental Figure 6). Taken together, this data is consistent with RA signaling being a positive regulator of the Ret-Gfra1-Gdnf genetic network and critical for NCC entry and colonization of the GI tract. Interestingly, the Ret gene contains a putative retinoic acid response element (RARE) that binds retinoic acid receptors in the promoter/enhancer region upstream of the Ret transcriptional start site(92). We found using RNA sequencing data that Rarβ was downregulated over 2-fold in Rdh10trex/trex embryos (Supplemental Table 1). Furthermore, a cis- regulatory element variant exists in humans within the enhancer region of RET that disrupts the binding of RARβ, thereby reducing RET expression(49). The presence of this variant increases the risk of HSCR in the human population by 1.7-fold and collectively suggests that RA directly regulates RET during normal ENS formation and in the pathogenesis of HSCR. Consistent with this idea, constitutive expression of a dominant-negative RAR, which blocks RA signaling, in NCC, diminishes Ret signaling in the ENS, resulting in aganglionosis (83) . Conversely, exogenous RA can upregulate Ret in vagal NCC and promote their migration into the foregut (76).The upregulation of Ret by RA has been associated with increased tyrosine phosphorylation of Ret by Gdnf, implying RA can modulate Gdnf responsiveness(93).(83) . Conversely, exogenous RA can upregulate Ret in vagal NCC and promote their migration into the foregut (76).The upregulation of Ret by RA has been associated with increased tyrosine phosphorylation of Ret by Gdnf, implying RA can modulate Gdnf responsiveness(93). Further evidence for an interaction between RA and other Ret pathway genes is evident from studies in which neurospheres treated with both RA and Gdnf, exhibited increased migration and increased neuronal connections(94). Moreover, RA also stimulates both Gdnf and Gfrα1 expression in vitro(93, 95). Taken together, our data places Rdh10-mediated RA signaling upstream of the Ret-Gfra1-Gdnf signaling axis during vagal NCC entry into the foregut, which is essential for ENS formation, and when disrupted contributes to the pathogenesis of intestinal aganglionosis. Although downregulation of Ret-Gdnf-Gfrα1 expression could alone account for the intestinal aganglionosis phenotype in Rdh10trex/trex embryos, our comparative RNA sequencing revealed misregulation of numerous other genes associated with NCC, ENS formation and HSCR etiology, including Gfrα1, Phox2b, Pax3, Hoxb5, Ednrb, Ecel1, and Col6a4 (Figure 7, Supplemental Table 1). This aligns with a recent report that in vitro RA treatment is sufficient to induce expression of Hoxb5, Phox2b and Pax3 (96). Interestingly, the role of these genes in HSCR pathogenesis has been linked to regulating Ret(40, 41, 48, 97, 98). Gfrα1 as a co-receptor for Gdnf, is a major component of the Ret-Gdnf-Gfrα1 signaling axis. Phox2b null mutant embryos lack Ret in migrating ENCC(41) and Phox2b has been shown to independently regulate .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint Ret expression in vitro(40). Both Phox2b and Pax3 null mutants display total intestinal aganglionosis and mutations in PHOX2B have been reported in human cases of HSCR(41, 47, 97, 99-101). Pax3 interacts with Sox10 to bind an enhancer region of the Ret promoter and regulate its expression(97, 98). Hoxb5 mutant mice present with an intestinal hypoganglionosis phenotype(50) and furthermore, Hoxb5 forms a complex with Nkx2.1, which synergistically regulates Ret activity, as well as, coordinates with Phox2b and Pax3 to mediate expression at the Ret promoter(40, 50). The Endothelin pathway which also plays a central role in regulating vagal NCC migration and development in the gut(102) is disrupted in Rdh10trex/trex embryos, as evidenced by decreased expression of Ednrb and Ecel1. Ednrb and Ecel1 loss-of-function mouse mutants exhibit distal colonic aganglionosis, and Ednrb mutants also display pigmentation defects, which together with HSCR phenocopies Waardenburg-syndrome in humans(103, 104). Variants of Ednrb increase the risk of HSCR(105, 106) and Ednrb interactions with Sox10 enhance the penetrance and severity of HSCR phenotypes. Consistent with these findings, compound Ednrbsl/sl;Sox10Dom/+(107) double mutants exhibit total intestinal aganglionosis. Collectively these genes, identified by our comparative RNA sequencing, interact extensively in ENS formation and HSCR pathogenesis (Figure 7). Taken together with our data, this suggests that Rdh10-mediated RA signaling acts upstream of multiple signaling networks that coordinate vagal NCC migration and entry into the foregut during ENS formation and that are associated with the etiology of aganglionosis. ECM and cell adhesion components are altered in Rdh10trex/trex embryos Our RNA-sequencing data also revealed that Rdh10 loss-of-function results in altered focal cell adhesion and ECM composition (Figure 6). This is important as changes in adhesion and in the ECM influence cell migration and contribute to enteric nervous system defects as non-heritable factors in the etiology and pathogenesis of HSCR (72, 108-111). Many cell adhesion molecules expressed by vagal NCC promote their migration. For example, we found that L1cam is reduced in Rdh10trex/trex mutants, and interestingly, L1cam loss-of-function disrupts vagal NCC chain migration resulting in a delay in gut colonization (65). Furthermore, mutations in the L1cam gene were the first to associate a neural cell adhesion molecule with HSCR, (112) and its location on the X-chromosome is thought to contribute to male predominance in patients (113). Interestingly, L1cam acts as a modifier of the vagal NCC network through its interactions with Sox10 and Ednrb, which together increase the incidence of aganglionosis (66, 86).(72, 108-111). Although it remains to be determined if RA directly regulates L1cam, our data provides further support for Rdh10-mediated RA signaling as a regulator of the genetic network that facilitates the migration of vagal NCC and their entry into the foregut. Th e ECM is known to influence NCC migration and our RNA-sequencing data revealed considerable transcriptional changes in individual components in the interstitial and extracellular matrix. RA can regulate many of the affected matrix components including glycoproteins, laminin, fibronectin, tenascin-c, and collagen(68-70, 114-118). With respect to .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint members of the collagen family we found that the levels of Col1A1, Col1A2, Col2A1, Col3A1, Col4A2, Col4A6 and Col6A3, in addition to many others (Figure 8, Supplemental Table 3), were increased in Rdh10trex/trex embryos compared to controls. Increased COL I, COL III and COLVI have been observed surrounding the myenteric plexus in patients with HSCR(54) with high levels of COL IV in aganglionic gut segments (119). Additionally, the enrichment of collagen is consistent with the observation that an increase in ColVI restricts NCC migration in the pathogenesis of distal colonic aganglionosis(54). Furthermore COLVI has been posited to contribute to the high incidence of HSCR in patients with Down syndrome as several of its subunit genes are located on chromosome 21(54, 111). The important role of collagen in HSCR pathogenesis can be explained in part through its abundance in the gut mesenchyme where it contributes to nearly 50% of ECM stiffness (120). Increased collagen concentration or deposition increases ECM stiffness which has subsequently been shown to restrict NCC migration in 3D gut explant cultures(72). Our data therefore reveals the importance of Rdh10-mediated RA signaling in regulating ECM composition, particularly with respect to collagen, to ensure proper vagal NCC migration. Thus, perturbation of cell adhesion and ECM composition in Rdh10trex/trex embryos may provide additional barriers to vagal NCC migration and entry into the foregut, during ENS formation and in the pathogenesis of intestinal aganglionosis.

Conclusion

RDH10 oxidation of vitamin A plays a critical role in the synthesis of retinoic acid during embryogenesis(18, 19). RDH10 converts all-trans-retinol to all-trans-retinal (19, 23, 24) in a reversible manner with DHRS3, which serves as a key regulatory check-point in the pathway(19, 23, 24, 121-123). In this study, we uncovered the tissue specific role and mechanistic effects of Rdh10-mediated RA signaling during the early phases of ENS development. We showed that Rdh10 is required during a narrow 48-hour window in which it regulates the microenvironment through which NCC migrate during their invasion of the foregut. This is fundamentally important for normal ENS formation, and when perturbed results in intestinal aganglionosis. Rdh10-mediated RA signaling functions in a paracrine manner to regulate the activity of key factors in the vagal NCC gene regulatory network including Ret-Gdnf-Gfrα1, together with Phox2b, Pax3, Ednrb, Ecel1, Hoxb5 and Col6a4. Each of these genes has previously been associated with the etiology and pathogenesis of HSCR, through the critical roles they play in governing vagal NCC development. Rdh10-mediated RA signaling also influences cell adhesion and ECM composition with respect to laminin and collagen among many others, the perturbation of which may restrict NCC migration in association with the pathogenesis of HSCR. Collectively our data illustrates the pleiotropic effects of Rdh10-mediated RA signaling in regulating vagal NCC and their microenvironment during migration and entry into the foregut (Figure 9). We investigated the spatiotemporal contributions of Rdh10-mediated RA signaling during ENS development and found that Rdh10 is a novel key regulator of vagal NCC migration and invasion of the GI tract during ENS formation and in the pathogenesis of intestinal .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint aganglionosis. Similarly, a recent study in mice showed that conditional activation of a dominant negative RAR in premigratory and migratory NCC, that is prior to their invasion of the foregut, also resulted in intestinal aganglionosis(83). Interestingly conditional activation at later stages, after foregut entry, resulted in only a mild hypoganglionosis phenotype. Furthermore, pharmacological and genetic modulation of the RA signaling pathway in zebrafish revealed that inhibition of RA signaling delays vagal NCC chain migration, resulting in distal aganglionosis(77). Conversely, exogenous RA expands the vagal NCC population leading to an increase in enteric neurons. Collectively, this illustrates the dynamic dual phase temporal contribution of RA signaling to vagal NCC development during ENS formation. RA signaling is firstly required for NCC invasion of the foregut, but then secondly is required after entry for the continued migration and differentiation of NCC throughout the GI tract. In addition, the RA signaling pathway also seems to be important for postnatal gut function as well, since patients with biallelic variants of ALDH1A2, present with defects in gut motility.(124) Our findings highlight the importance of Rdh10, vitamin A metabolism and RA signaling as both genetic and non-heritable environmental contributors to intestinal aganglionosis and possibly HSCR. Collectively, this demonstrates the importance of maintaining precise, appropriate levels of vitamin A and RA during pregnancy, and provides potential avenues for non-surgical prevention of HSCR by identifying and treating populations and pregnant mothers at high risk for vitamin A deficiency.

Materials and methods

Mouse lines: Mice were housed in the Laboratory Animal Services Facility at the Stowers Institute for Medical Research and all animal experiments were performed in accordance with IACUC approved protocol 2022-143. Rdh10 trex/+, Rdh10βgeo/+, Aldh1a2gri/+, RARE-lacZ, Mef2c- F10N-lacZ and ERT2Cre (B6.129-Gt(ROSA)26Sortm1(cre/ERT2)Tyj/J; Jax stock #008463) mouse lines were maintained as previously described (18-20, 125),(126) . Rdh10flox/flox mice were created using Knockout Mouse Project Repository (KOMP) embryonic stem cells. Control embryos described in experiments using Rdh10trex/trex embryos were either wild-type or heterozygous littermates. Control embryos described in experiments using Rdh10fx/fx x Cre lines were either Rdh10fx/+; ERT2Cre+, Rdh10fx/+ or Rdh10fx/fx littermates. For embryo staging, the morning of identification of the vaginal plug was defined as E0.5. All experiments were performed with a minimum N=5 unless specifically stated otherwise, and which were obtained from multiple litters for rigor and reproducibility. Although, sex was not specifically recorded for each embryo, our study included analyses of male and female embryos, with our cumulative findings reported. Gut organ culture: E11.5 embryos were dissected from the uterus and placed on ice cold PBS. Guts (esophagus, stomach, small and large intestines with accompanying mesentery) were isolated in fresh PBS, placed in L15 Leibowitz medium (Sigma) and then transferred onto a Millicell 0.4μm cell culture insert (Millipore) in a 6-well tissue culture dish (Millipore). The L15 medium was replaced with 400μL OptiMEM (Invitrogen) with 1mM L-Glutamine (Life Technologies Glutamax) and Penicillin/Streptomycin (Invitrogen). The guts were cultured in a .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint 37°C incubator with 5% CO2 and the media was changed every 2 days as previously described. (127) For retinoid-supplemented cultures, guts were prepared as described above, and 1μM all- trans-retinoic acid (Sigma R2625) or 1μM all-trans-retinal (Sigma R2500) was added to the culture media (a 10-6 M concentration of RA produces morphological changes in 50% of cultured guts (128)). Organ Immunohistochemistry: E11.5-E18.5 embryos were dissected from the uterus into ice cold PBS. Isolated guts and cultured guts were fixed in 4% paraformaldehyde in PBS (PFA) overnight at 4°C. Guts were washed 3 x 5 minutes in PBS with 0.1% TritonX100 (PBT) at room temperature, followed by blocking and antibody hybridization in 10% heat-inactivated lamb serum in PBT. Non-specific antibody binding was blocked by a 20-minute incubation with blocking solution, after which primary antibody was applied overnight at 4°C in fresh blocking solution. Guts were then washed 5 x 1 hour in PBT at room temperature. Secondary antibody hybridization was performed in blocking solution overnight at 4°C, followed by 3 x 20-minute washes in PBT at room temperature. The guts were then stained with DAPI dilactate, 10 µg/ml in PBT, for 10 minutes or longer at room temperature and immersed into Vectashield with DAPI (Vector Laboratories) for storage and imaging. In situ hybridization: E8.5-E11.5 embryos were dissected from the uterus and into ice cold DEPC-PBS and then fixed in 4% paraformaldehyde (PFA) in phosphate buffered solution (PBS) overnight at 4°C. The following day, the embryos were dehydrated through an increasing methanol series diluted in DEPC-PBS 1% Tween (PBS-Tw), washing for 10 minutes at each step before being stored in 100% methanol at -20°C overnight. Embryos were rehydrated through a decreasing methanol series followed by 3 x 5 minute washes in PBS-Tw. The embryos were then treated with 10μg/mL Proteinase K in PBS-Tw without shaking. Proteinase K treatment time varied based on the age of the embryos. The embryos were washed 5 minutes in 2mg/mL glycine in PBS-Tw, then 2 x 5 minutes in PBS-Tw and were re-fixed in 4% paraformaldehyde/0.2% glutaraldehyde solution in PBS for 20 minutes. The embryos were then washed 3 x 5 minutes in PBS-Tw, rinsed in 65°C pre-warmed hybridization solution (for hybridization solution, MABT and NTMT recipes, see (129)), and placed in fresh pre-warmed hybridization solution for 2 hours at 65°C. Probe was added to fresh hybridization solution into which the embryos were incubated overnight at 65°C. The embryos were washed in pre- warmed hybridization solution 2 x 30 minutes, then 3 x 30 minutes at 65°C with Formamide Wash Solution (50% formamide, 1xSSC, pH4.5, 0.1% Tween). Next, the embryos were washed for 30 minutes in a 1:1 formamide wash solution: MABT, then 3 x 5 minutes MABT. The embryos were then blocked in MABT + 2% Boehringer Blocking Reagent (BBR) for 1 hour at room temperature, then an additional 1-2 hours in MABT + 2% BBR +20% heat-inactivated goat serum. The embryos were incubated overnight at 4°C in 1:2000 anti-DIG in MABT + 2% BBR + 20% heat-treated goat serum, rinsed, and then washed 2 x 15 minutes in MABT, then 5-7 x 1.5 hour in MABT, followed by an overnight MABT wash at room temperature. For anti-DIG antibody detection, the embryos were washed 3 x 10 minutes in NTMT, then incubated in the dark in NBT/BCIP reaction mix (3.375 µl/mL of 100mg/mL NBT and 3.5µL/mL of 50mg/mL BCIP per 1mL reaction mix) until the color reaction was deemed complete. Finally, the embryos were washed with PBS-Tw and fixed with 4% PFA/0.1% glutaraldehyde. Gdnf in situ hybridization .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint required 50mg/ml Proteinase K in PBS-Tw at room temperature for 15 minutes, with occasional mixing. For color development, the embryos were incubated in the dark in NBT/BCIP reaction mix for up to 7 days with fresh reaction mix added every 24 hours. Whole embryo immunohistochemistry: E10.5-E11.5 embryos were dissected from the uterus and placed in ice cold PBS. Embryos were fixed in 4% PFA overnight at 4°C, then washed in PBS and transferred through an increasing methanol series into 100% methanol. Tissues and embryos to be immunostained were permeabilized in Dent’s bleach (MeOH:DMSO:30%H2O2, 4:1:1) for 2 hours at room temperature, then washed with 100% methanol and transferred through a decreasing methanol series into PBS. Blocking and antibody hybridization was performed in 0.1M Tris pH7.5/0.15M NaCl buffer. Non-specific antibody binding was blocked by a two-hour incubation in Tris/NaCl buffer with 3% Bovine Serum Albumin with gentle rocking. Primary antibody hybridization was performed in blocking buffer overnight at 4oC. Following primary antibody hybridization specimens were washed 5 x 1 hour in PBS at room temperature. Secondary antibody hybridization was performed in blocking buffer overnight at 4 oC, followed by 3 X 20 minutes washes in PBS at room temperature. Specimens were stained with DAPI dilactate, 10 µg/ml in PBS, for 10 minutes or longer at room temperature or overnight at 4oC. Prior to imaging, immunostained specimens were cleared with ScaleA2 for at least 5 days (130), or ClearT2 for at least 2 days (131).Prior to imaging, immunostained specimens were cleared with ScaleA2 for at least 5 days (130), or ClearT2 for at least 2 days (131). Glass imaging wells were prepared by coating a Teflon O-ring with vacuum grease and affixing the ring to a glass depression slide. ScaleA2 or ClearT2 cleared specimens were placed into the well and the well filled with ScaleA2 or ClearT2. A coverslip was then adhered to the vacuum grease coated O-ring. Antibodies: The following antibodies were used: βIII neuronal tubulin antibody (TUJ1), 1:1000, (MMS-435P or MRB-435P, Covance); GFP antibody, 1:500, (A6455 Invitrogen/Molecular Probes); Caspase 3 antibody, 1:500 (D175 Cell Signaling); AP2α antibody 1:500 (3B5, DSHB); Phox2b, 1:500 (gift from Dr Hideki Enomoto), ColVI 1:500 (Ab6588 Abcam); Sox10, 1:100 (AF2864 R&D System); Alexa Fluor 488, 1/500, (A21206 Invitrogen/Molecular Probes); and Alexa Fluor 546, 1/500, (A11030 Invitrogen/Molecular Probes). β-galactosidase staining: Rdh10 trex/+ mice were mated to RARE-lacZ, Mef2c-F10N-lacZ and Wnt1;R26R (126) mice and embryos/embryonic tissues were collected at E9.5-12.5. Rdh10βgeo/+ mice were mated to FVB/NJ and embryos were collected at E8.5-10.5. Embryos were fixed with 2% Paraformaldehyde + 0.25% Glutaraldehyde, and then stained using a β-galactosidase staining solution kit (Chemicon/Millipore) according to the manufacturer’s instructions(132). Retinal gavage: 312.5μg of all-trans-retinal (Sigma R2500) in 100µL corn oil (3.125mg/mL) was administered to pregnant females via oral gavage on the morning and night of E7.5, E8.5, and E9.5 (20). Tamoxifen gavage: 5mg of tamoxifen (Sigma T5648) was administered to pregnant females via oral gavage at varying embryonic days post coitum in 100µL corn oil (50mg/mL). To prevent .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint pregnancy loss, 1mg of progesterone (Sigma P3972) was co-administered (10mg/mL). To dissolve tamoxifen, 500mg of tamoxifen was initially dissolved in 1mL of ethanol and then 9mL of corn oil was added and warmed to 37oC until all the tamoxifen went into solution (approximately 8 hours). Using the R26R; ERT2Cre reporter line, 5mg tamoxifen + 1mg progesterone dosage results in complete Cre recombination within 24 hours of administration. Imaging: Confocal images were captured on an upright Zeiss LSM510 or LSM700 Pascal equipped with a 405 nm laser. For each specimen, a z-stack of images was collected and processed as a maximum intensity projection. Stacks of light microscope images were taken on a Leica MZ9.5 stereomicroscope and assembled in Helicon Focus. qRT-PCR: 500ng of mouse RNA harvested from the vagal region of E9.0- E9.5 embryos delimited by the otic vesicle to the seventh somite was used as a template in a Superscript III (Life Technologies) reverse transcription kit reaction (40µl) utilizing random hexamer primers. The reaction volume was diluted 10 times and 2µl of cDNA was used in 10µl total qPCR reactions prepared with PerfeCTa SYBR Green FastMix, ROX (Quanta Biosciences) and cycled on an ABI 7900HT according to Quanta Biosciences standard protocols. Analysis of the fluorescence curves was performed using Life Technologies SDS2.4 software. All curves that showed errors as determined by the SDS2.4 software or that were above 35 Ct were discarded. The remaining Ct values were exported and analyzed using the Biogazelle qBase plus version 2.4. Three appropriate endogenous controls (M-value < .5) for each sample set were selected from a panel of five primer sets using geNorm in qBase plus. All primer sets (Supplemental Table 4) used were experimentally determined to be within 10% of ideal efficiency. Individual gene results were graphed with standard error bars, and relative expression (of all genes) results were graphed with 95% confidence intervals. RNA Sequencing: The vagal (somite 1-7) region of E9.5 embryos was used for RNA Seq (GSE166625) and QPCR experiments. Total RNA was extracted using a Qiagen RNEasy kit according to the manufacturer’s protocol. Samples were run on the Agilent 2100 BioAnalyzer and subsequently used to create polyA strand-specific libraries. Samples were sequenced on the Illumina HiSeq 2500 platform. Sequences for each RNA sample were aligned using TopHat (v2.0.10). The reference genome and annotation files used for the alignment were from the UCSC mm10 genome and the ensembl build 77. Expression levels for genes were calculated using R and Bioconductor. TopHat aligned reads were tabulated using the GenomicFeatures library, and differential expression was assessed using EdgeR(133). The experiment was performed in quadruplicate on 4 mutant and 4 wild-type littermates. Reads were counted for 55421 genes. However, after filtering for a sum of at least 10 reads across all samples, this left 20,883 genes remaining for analysis with edgeR. The top up regulated genes with ≥ 1.74 fold change and a p-value < 0.05 were examined for enrichment of GO terms from the Biological Process Ontology. Pathway enrichment analysis was also performed on all genes with an adjusted p-value of 0.05 or less (1992 genes) using Signaling Pathway Impact Analysis (SPIA), Database for Annotation, Visualization, and Integrated Discovery (DAVID)(134, 135), and ToppGene Suite(136, 137) developed at the Cincinnati Children's Hospital Medical Center to assess pathway changes from databases that include the Kyoto Encyclopedia of Genes and .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint Genomes (KEGG) Reactome, MSigDB C2 BIOCARTA, and Biosystems: Pathway Interaction Database. Ingenuity Pathway Analysis (IPA, Qiagen) software was also used to identify 128 genes that were differentially regulated that function in ECM organization, binding and/or adhesion. Additionally, select genes that were identified from the RNA Seq data that function in ENS formation, regulation of Ret, and HSCR pathogenesis were visualized in a gene interaction map using Cytoscape(138) software. The RNA Seq data referenced in this paper can be found in NCBI’s Gene Expression Omnibus(139, 140) with GEO Series accession number GSE166625 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE166625). Sirius Red staining: Embryos were collected at E9.5 and fixed with 4% PFA overnight at 4°C. The embryos were then rinsed in PBS and dehydrated in 70% ethanol and embedded in paraffin before being sectioned at 10µm. To identify collagen fibers in the anterior foregut, sections were stained with Sirius red and counter-stained with phosphomolybidic acid (PMA) to prevent auto-fluorescence during confocal imaging as previously described(141). The sections were imaged on an upright Zeiss LSM700 Pascal equipped with a 405 nm laser. 4 mutant and 5 wild- type embryos were analyzed across two litters. The fluorescent intensity of the Sirius red stain was measured across three consecutive sections of the anterior foregut for each embryo. Image J software(142) was used to quantify fluorescent intensity within a defined region of the anterior foregut. Statistical analysis between Rdh10 trex/trex and control littermates was performed using an unpaired student t-test with a calculated p-value of 0.0005.

Acknowledgements

We thank members of the Trainor lab and the Neurogastroenterology community for their continual support and constructive feedback on this work. We greatly appreciate the Laboratory Animal Services Facility at the Stowers Institute for their care and maintenance of our mouse colonies. We thank the Molecular Biology core facility, particularly William McDowell for advice and analysis on qRT-PCR experiments. RARE-lacZ mice were a generous gift from J Rossant and we thank Dr. Hideki Enomoto for sharing the Phox2b antibody, Dr. Robert Heuckeroth for the Ret plasmid and Dr. Dipa Natarajan and Vassilis Pachnis for Ret, GDNF, Gfrα1 and EDNRB plasmids. We are extremely grateful to Mark Miller for generating the artwork in Figure 9. Research reported in this publication was supported by Stowers Institute for Medical Research (PAT), National Institute of Diabetes and Digestive and Kidney Diseases F30DK096842 (NEBT), and Madison and Lila Self Graduate Fellowship from the University of Kansas (SRS). Original data underlying this manuscript can be accessed from the Stowers Original Data Repository at http://www.stowers.org/research/publications/LIBPB-1603. Conflict of Interest Statement: The authors have no conflicts of interest to declare. Abbreviations enteric nervous system (ENS); neural crest cells (NCC); Hirschsprung disease (HSCR); retinoic acid (RA); retinol dehydrogenase 10 (Rdh10); N-ethyl-N-nitrosourea (ENU); retinol binding protein 4 (RBP4); retinoic acid receptor (RAR); retinoid receptor (RXR); extracellular matrix composition (ECM); gene ontology (GO); Signaling Pathway Impact Analysis (SPIA); Kyoto Encyclopedia of Genes and Genomes (KEGG); Ingenuity Pathway Analysis (IPA); CREB-binding protein (CBP) .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint

References

1 Tremblay, K.D. and Zaret, K.S. (2005) Distinct populations of endoderm cells converge to generate the embryonic liver bud and ventral foregut tissues. Dev Biol, 280, 87-99. 2 Tam, P.P., Khoo, P.L., Lewis, S.L., Bildsoe, H., Wong, N., Tsang, T.E., Gad, J.M. and Robb, L. (2007) Sequential allocation and global pattern of movement of the definitive endoderm in the mouse embryo during gastrulation. Development, 134, 251-260. 3 Boland, M. (2016) Human digestion--a processing perspective. J Sci Food Agric, 96, 2275-2283. 4 Schulze, K. (2006) Imaging and modelling of digestion in the stomach and the duodenum. Neurogastroenterol Motil, 18, 172-183. 5 Neutra, M.R., Pringault, E. and Kraehenbuhl, J.P. (1996) Antigen sampling across epithelial barriers and induction of mucosal immune responses. Annu Rev Immunol, 14, 275-300. 6 Gebert, A., Rothkotter, H.J. and Pabst, R. (1996) M cells in Peyer's patches of the intestine. Int Rev Cytol, 167, 91-159. 7 Whitehouse Fr, K.J. (1948) Myenteric plexus in congenital megacolon: Study of eleven cases. Archives of Internal Medicine, 82, 75-111. 8 Parisi, M.A. (2006) Hirschsprung Disease Overview. GeneReviews, in press. 9 Burns, A.J., Goldstein, A.M., Newgreen, D.F., Stamp, L., Schafer, K.H., Metzger, M., Hotta, R., Young, H.M., Andrews, P.W., Thapar, N. et al. (2016) White paper on guidelines concerning enteric nervous system stem cell therapy for enteric neuropathies. Dev Biol, 417, 229-251. 10 Burns, A.J. and Thapar, N. (2014) Neural stem cell therapies for enteric nervous system disorders. Nat Rev Gastroenterol Hepatol, 11, 317-328. 11 Hotta, R., Stamp, L.A., Foong, J.P., McConnell, S.N., Bergner, A.J., Anderson, R.B., Enomoto, H., Newgreen, D.F., Obermayr, F., Furness, J.B. et al. (2013) Transplanted progenitors generate functional enteric neurons in the postnatal colon. The Journal of Clinical Investigation, 123, 1182-1191. 12 Stamp, L.A. and Young, H.M. (2017) Recent advances in regenerative medicine to treat enteric neuropathies: use of human cells. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society, 29. 13 Gershon, M.D. (2007) Transplanting the enteric nervous system: a step closer to treatment for aganglionosis. Gut, 56, 459-461. 14 Hotta, R., Natarajan, D. and Thapar, N. (2009) Potential of cell therapy to treat pediatric motility disorders. Semin Pediatr Surg, 18, 263-273. 15 Brooks, A.S., Oostra, B.A. and Hofstra, R.M. (2005) Studying the genetics of Hirschsprung's disease: unraveling an oligogenic disorder. Clin Genet, 67, 6-14. 16 Butler Tjaden, N.E. and Trainor, P.A. (2013) The developmental etiology and pathogenesis of Hirschsprung disease. Transl Res, 162, 1-15. 17 Hao, M.M., Foong, J.P., Bornstein, J.C., Li, Z.L., Vanden Berghe, P. and Boesmans, W. (2016) Enteric nervous system assembly: Functional integration within the developing gut. Dev Biol, 417, 168- 181. 18 Sandell, L.L., Iulianella, A., Melton, K.R., Lynn, M., Walker, M., Inman, K.E., Bhatt, S., Leroux- Berger, M., Crawford, M., Jones, N.C. et al. (2011) A phenotype-driven ENU mutagenesis screen identifies novel alleles with functional roles in early mouse craniofacial development. genesis, 49, 342- 359. 19 Sandell, L.L., Sanderson, B.W., Moiseyev, G., Johnson, T., Mushegian, A., Young, K., Rey, J.P., Ma, J.x., Staehling-Hampton, K. and Trainor, P.A. (2007) RDH10 is essential for synthesis of embryonic retinoic acid and is required for limb, craniofacial, and organ development. Genes & Development, 21, 1113-1124. .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint 20 Farjo, K.M., Moiseyev, G., Nikolaeva, O., Sandell, L.L., Trainor, P.A. and Ma, J.-x. (2011) RDH10 is the primary enzyme responsible for the first step of embryonic Vitamin A metabolism and retinoic acid synthesis. Developmental Biology, 357, 347-355. 21 Kurosaka, H., Wang, Q., Sandell, L., Yamashiro, T. and Trainor, P.A. (2017) Rdh10 loss-of-function and perturbed retinoid signaling underlies the etiology of choanal atresia. Hum Mol Genet, in press. 22 Cunningham, T.J., Chatzi, C., Sandell, L.L., Trainor, P.A. and Duester, G. (2011) Rdh10 mutants deficient in limb field retinoic acid signaling exhibit normal limb patterning but display interdigital webbing. Developmental Dynamics, 240, 1142-1150. 23 Billings, S.E., Pierzchalski, K., Butler Tjaden, N.E., Pang, X.-Y., Trainor, P.A., Kane, M.A. and Moise, A.R. (2013) The retinaldehyde reductase DHRS3 is essential for preventing the formation of excess retinoic acid during embryonic development. The FASEB Journal, 27, 4877-4889. 24 D'Aniello, E., Ravisankar, P. and Waxman, J.S. (2015) Rdh10a Provides a Conserved Critical Step in the Synthesis of Retinoic Acid during Zebrafish Embryogenesis. PLoS One, 10, e0138588. 25 Duester, G. (2008) Retinoic Acid Synthesis and Signaling during Early Organogenesis. Cell, 134, 921-931. 26 Niederreither, K., Vemparala, S., Dollé, P. and Chambon, P. (1999) Embryonic retinoic acid synthesis is essential for early mouse post-implantation development. Nature Genetics, 21, 444-448. 27 Niederreither, K., Vermot, J., Fraulob, V., Chambon, P. and Dollé, P. (2002) Retinaldehyde dehydrogenase 2 (RALDH2)- independent patterns of retinoic acid synthesis in the mouse embryo. Proceedings of the National Academy of Sciences, 99, 16111-16116. 28 Lohnes, D., Mark, M., Mendelsohn, C., Dolle, P., Dierich, A., Gorry, P., Gansmuller, A. and Chambon, P. (1994) Function of the retinoic acid receptors (RARs) during development (I). Craniofacial and skeletal abnormalities in RAR double mutants. Development, 120, 2723-2748. 29 Mendelsohn, C., Lohnes, D., Decimo, D., Lufkin, T., LeMeur, M., Chambon, P. and Mark, M. (1994) Function of the retinoic acid receptors (RARs) during development (II). Multiple abnormalities at various stages of organogenesis in RAR double mutants. Development, 120, 2749-2771. 30 Cunningham, T.J. and Duester, G. (2015) Mechanisms of retinoic acid signalling and its roles in organ and limb development. Nat Rev Mol Cell Biol, 16, 110-123. 31 Niederreither, K. and Dolle, P. (2008) Retinoic acid in development: towards an integrated view. Nat. Rev. Genet., 9, 541-553. 32 Sandell, L.L., Lynn, M.L., Inman, K.E., McDowell, W. and Trainor, P.A. (2012) RDH10 Oxidation of Vitamin A Is a Critical Control Step in Synthesis of Retinoic Acid during Mouse Embryogenesis. PLoS ONE, 7, e30698. 33 Cunningham, T.J., Zhao, X., Sandell, L.L., Evans, S.M., Trainor, P.A. and Duester, G. (2013) Antagonism between retinoic acid and fibroblast growth factor signaling during limb development. Cell reports, 3, 1503-1511. 34 Kumar, S., Sandell, L.L., Trainor, P.A., Koentgen, F. and Duester, G. (2012) Alcohol and aldehyde dehydrogenases: Retinoid metabolic effects in mouse knockout models. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1821, 198-205. 35 Uesaka, T. and Enomoto, H. (2010) Neural precursor death is central to the pathogenesis of intestinal aganglionosis in Ret hypomorphic mice. J Neurosci, 30, 5211-5218. 36 Taraviras, S., Marcos-Gutierrez, C.V., Durbec, P., Jani, H., Grigoriou, M., Sukumaran, M., Wang, L.C., Hynes, M., Raisman, G. and Pachnis, V. (1999) Signalling by the RET receptor tyrosine kinase and its role in the development of the mammalian enteric nervous system. Development, 126, 2785-2797. 37 Natarajan, D., Marcos-Gutierrez, C., Pachnis, V. and de Graaff, E. (2002) Requirement of signalling by receptor tyrosine kinase RET for the directed migration of enteric nervous system progenitor cells during mammalian embryogenesis. Development, 129, 5151-5160. .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint 38 Young, H.M., Hearn, C.J., Farlie, P.G., Canty, A.J., Thomas, P.Q. and Newgreen, D.F. (2001) GDNF is a chemoattractant for enteric neural cells. Dev Biol, 229, 503-516. 39 Durbec, P.L., Larsson-Blomberg, L.B., Schuchardt, A., Costantini, F. and Pachnis, V. (1996) Common origin and developmental dependence on c-ret of subsets of enteric and sympathetic neuroblasts. Development, 122, 349-358. 40 Leon, T.Y., Ngan, E.S., Poon, H.C., So, M.T., Lui, V.C., Tam, P.K. and Garcia-Barcelo, M.M. (2009) Transcriptional regulation of RET by Nkx2-1, Phox2b, Sox10, and Pax3. J Pediatr Surg, 44, 1904-1912. 41 Pattyn, A., Morin, X., Cremer, H., Goridis, C. and Brunet, J.F. (1999) The homeobox gene Phox2b is essential for the development of autonomic neural crest derivatives. Nature, 399, 366-370. 42 Cacalano, G., Farinas, I., Wang, L.C., Hagler, K., Forgie, A., Moore, M., Armanini, M., Phillips, H., Ryan, A.M., Reichardt, L.F. et al. (1998) GFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidney. Neuron, 21, 53-62. 43 Enomoto, H., Araki, T., Jackman, A., Heuckeroth, R.O., Snider, W.D., Johnson, E.M., Jr. and Milbrandt, J. (1998) GFR alpha1-deficient mice have deficits in the enteric nervous system and kidneys. Neuron, 21, 317-324. 44 Yanagisawa, H., Yanagisawa, M., Kapur, R.P., Richardson, J.A., Williams, S.C., Clouthier, D.E., de Wit, D., Emoto, N. and Hammer, R.E. (1998) Dual genetic pathways of endothelin-mediated intercellular signaling revealed by targeted disruption of endothelin converting enzyme-1 gene. Development, 125, 825-836. 45 Eketjall, S. and Ibanez, C.F. (2002) Functional characterization of mutations in the GDNF gene of patients with Hirschsprung disease. Hum Mol Genet, 11, 325-329. 46 Hofstra, R.M., Valdenaire, O., Arch, E., Osinga, J., Kroes, H., Loffler, B.M., Hamosh, A., Meijers, C. and Buys, C.H. (1999) A loss-of-function mutation in the endothelin-converting enzyme 1 (ECE-1) associated with Hirschsprung disease, cardiac defects, and autonomic dysfunction. Am J Hum Genet, 64, 304-308. 47 Amiel, J., Laudier, B., Attie-Bitach, T., Trang, H., de Pontual, L., Gener, B., Trochet, D., Etchevers, H., Ray, P., Simonneau, M. et al. (2003) Polyalanine expansion and frameshift mutations of the paired- like homeobox gene PHOX2B in congenital central hypoventilation syndrome. Nat Genet, 33, 459-461. 48 Zhu, J., Garcia-Barcelo, M.M., Tam, P.K. and Lui, V.C. (2011) HOXB5 cooperates with NKX2-1 in the transcription of human RET. PloS one, 6, e20815. 49 Chatterjee, S., Kapoor, A., Akiyama, J.A., Auer, D.R., Lee, D., Gabriel, S., Berrios, C., Pennacchio, L.A. and Chakravarti, A. (2016) Enhancer Variants Synergistically Drive Dysfunction of a Gene Regulatory Network In Hirschsprung Disease. Cell, 167, 355-368 e310. 50 Lui, V.C., Cheng, W.W., Leon, T.Y., Lau, D.K., Garcia-Barcelo, M.M., Miao, X.P., Kam, M.K., So, M.T., Chen, Y., Wall, N.A. et al. (2008) Perturbation of hoxb5 signaling in vagal neural crests down- regulates ret leading to intestinal hypoganglionosis in mice. Gastroenterology, 134, 1104-1115. 51 Chatterjee, S., Nandakumar, P., Auer, D.R., Gabriel, S.B. and Chakravarti, A. (2019) Gene- and tissue-level interactions in normal gastrointestinal development and Hirschsprung disease. Proc Natl Acad Sci U S A, 116, 26697-26708. 52 Garcia-Barcelo, M.M., Miao, X., Lui, V.C., So, M.T., Ngan, E.S., Leon, T.Y., Lau, D.K., Liu, T.T., Lao, X., Guo, W. et al. (2007) Correlation between genetic variations in Hox clusters and Hirschsprung's disease. Ann Hum Genet, 71, 526-536. 53 Chan, K.K., Chen, Y.S., Yau, T.O., Fu, M., Lui, V.C., Tam, P.K. and Sham, M.H. (2005) Hoxb3 vagal neural crest-specific enhancer element for controlling enteric nervous system development. Dev Dyn, 233, 473-483. 54 Soret, R., Mennetrey, M., Bergeron, K.F., Dariel, A., Neunlist, M., Grunder, F., Faure, C., Silversides, D.W., Pilon, N. and Ente-Hirsch Study, G. (2015) A collagen VI-dependent pathogenic mechanism for Hirschsprung's disease. J Clin Invest, 125, 4483-4496. .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint 55 Ryan, H.E., Lo, J. and Johnson, R.S. (1998) HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J, 17, 3005-3015. 56 Lai, L., Bohnsack, B.L., Niederreither, K. and Hirschi, K.K. (2003) Retinoic acid regulates endothelial cell proliferation during vasculogenesis. Development, 130, 6465-6474. 57 Greenberg, J.H., Seppa, S., Seppa, H. and Tyl Hewitt, A. (1981) Role of collagen and fibronectin in neural crest cell adhesion and migration. Dev Biol, 87, 259-266. 58 Testaz, S., Delannet, M. and Duband, J. (1999) Adhesion and migration of avian neural crest cells on fibronectin require the cooperating activities of multiple integrins of the (beta)1 and (beta)3 families. J Cell Sci, 112 ( Pt 24), 4715-4728. 59 Perris, R., Paulsson, M. and Bronner-Fraser, M. (1989) Molecular mechanisms of avian neural crest cell migration on fibronectin and laminin. Dev Biol, 136, 222-238. 60 Singh, P., Carraher, C. and Schwarzbauer, J.E. (2010) Assembly of fibronectin extracellular matrix. Annu Rev Cell Dev Biol, 26, 397-419. 61 Hormann, H. and Jilek, F. (1980) Interaction of fibrinogen/fibrin and fibronectin with collagen. Artery, 8, 482-486. 62 Engvall, E., Ruoslahti, E. and Miller, E.J. (1978) Affinity of fibronectin to collagens of different genetic types and to fibrinogen. J Exp Med, 147, 1584-1595. 63 Nishida, S., Yoshizaki, H., Yasui, Y., Kuwahara, T., Kiyokawa, E. and Kohno, M. (2018) Collagen VI suppresses fibronectin-induced enteric neural crest cell migration by downregulation of focal adhesion proteins. Biochem Biophys Res Commun, 495, 1461-1467. 64 Tarca, A.L., Draghici, S., Khatri, P., Hassan, S.S., Mittal, P., Kim, J.S., Kim, C.J., Kusanovic, J.P. and Romero, R. (2009) A novel signaling pathway impact analysis. Bioinformatics (Oxford, England), 25, 75- 82. 65 Anderson, R.B., Turner, K.N., Nikonenko, A.G., Hemperly, J., Schachner, M. and Young, H.M. (2006) The Cell Adhesion Molecule L1 Is Required for Chain Migration of Neural Crest Cells in the Developing Mouse Gut. Gastroenterology, 130, 1221-1232. 66 Wallace, A.S., Schmidt, C., Schachner, M., Wegner, M. and Anderson, R.B. (2010) L1cam acts as a modifier gene during enteric nervous system development. Neurobiology of disease, 40, 622-633. 67 Fu, M., Barlow-Anacker, A.J., Kuruvilla, K.P., Bowlin, G.L., Seidel, C.W., Trainor, P.A. and Gosain, A. (2020) 37/67-laminin receptor facilitates neural crest cell migration during enteric nervous system development. FASEB J, 34, 10931-10947. 68 Meisler, N.T., Parrelli, J., Gendimenico, G.J., Mezick, J.A. and Cutroneo, K.R. (1997) All-trans- retinoic acid inhibition of Pro alpha1(I) collagen gene expression in fetal rat skin fibroblasts: identification of a retinoic acid response element in the Pro alpha1(I) collagen gene. J Invest Dermatol, 108, 476-481. 69 Wang, L., Tankersley, L.R., Tang, M., Potter, J.J. and Mezey, E. (2002) Regulation of the murine alpha(2)(I) collagen promoter by retinoic acid and retinoid X receptors. Arch Biochem Biophys, 401, 262- 270. 70 Wang, L., Tankersley, L.R., Tang, M., Potter, J.J. and Mezey, E. (2004) Regulation of alpha 2(I) collagen expression in stellate cells by retinoic acid and retinoid X receptors through interactions with their cofactors. Arch Biochem Biophys, 428, 92-98. 71 Segnani, C., Ippolito, C., Antonioli, L., Pellegrini, C., Blandizzi, C., Dolfi, A. and Bernardini, N. (2015) Histochemical Detection of Collagen Fibers by Sirius Red/Fast Green Is More Sensitive than van Gieson or Sirius Red Alone in Normal and Inflamed Rat Colon. PloS one, 10, e0144630. 72 Chevalier, N.R., Gazguez, E., Bidault, L., Guilbert, T., Vias, C., Vian, E., Watanabe, Y., Muller, L., Germain, S., Bondurand, N. et al. (2016) How Tissue Mechanical Properties Affect Enteric Neural Crest Cell Migration. Scientific reports, 6, 20927. .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint 73 Sato, Y. and Heuckeroth, R.O. (2008) Retinoic acid regulates murine enteric nervous system precursor proliferation, enhances neuronal precursor differentiation, and reduces neurite growth in vitro. Developmental Biology, 320, 185-198. 74 Niederreither, K., Vermot, J., Roux, I.L., Schuhbaur, B., Chambon, P. and Dollé, P. (2003) The regional pattern of retinoic acid synthesis by RALDH2 is essential for the development of posterior pharyngeal arches and the enteric nervous system. Development, 130, 2525-2534. 75 Fu, M., Sato, Y., Lyons-Warren, A., Zhang, B., Kane, M.A., Napoli, J.L. and Heuckeroth, R.O. (2010) Vitamin A facilitates enteric nervous system precursor migration by reducing Pten accumulation. Development, 137, 631-640. 76 Simkin, J.E., Zhang, D., Rollo, B.N. and Newgreen, D.F. (2013) Retinoic Acid Upregulates Ret and Induces Chain Migration and Population Expansion in Vagal Neural Crest Cells to Colonise the Embryonic Gut. PLoS ONE, 8, e64077. 77 Uribe, R.A., Hong, S.S. and Bronner, M.E. (2018) Retinoic acid temporally orchestrates colonization of the gut by vagal neural crest cells. Dev Biol, 433, 17-32. 78 Quadro, L., Blaner, W.S., Salchow, D.J., Vogel, S., Piantedosi, R., Gouras, P., Freeman, S., Cosma, M.P., Colantuoni, V. and Gottesman, M.E. (1999) Impaired retinal function and vitamin A availability in mice lacking retinol-binding protein. The EMBO journal, 18, 4633-4644. 79 Wendler, C.C., Schmoldt, A., Flentke, G.R., Case, L.C., Quadro, L., Blaner, W.S., Lough, J. and Smith, S.M. (2003) Increased fibronectin deposition in embryonic hearts of retinol-binding protein-null mice. Circulation research, 92, 920-928. 80 Niederreither, K., Vermot, J., Le Roux, I., Schuhbaur, B., Chambon, P. and Dolle, P. (2003) The regional pattern of retinoic acid synthesis by RALDH2 is essential for the development of posterior pharyngeal arches and the enteric nervous system. Development, 130, 2525-2534. 81 Gisser, J.M., Cohen, A.R., Yin, H. and Gariepy, C.E. (2013) A novel bidirectional interaction between endothelin-3 and retinoic acid in rat enteric nervous system precursors. PLoS One, 8, e74311. 82 Wright-Jin, E.C., Grider, J.R., Duester, G. and Heuckeroth, R.O. (2013) Retinaldehyde dehydrogenase enzymes regulate colon enteric nervous system structure and function. Dev Biol, 381, 28-37. 83 Gao, T., Wright-Jin, E.C., Sengupta, R., Anderson, J.B. and Heuckeroth, R.O. (2021) Cell- autonomous retinoic acid receptor signaling has stage-specific effects on mouse enteric nervous system. JCI Insight, 6. 84 Li, C., Hu, R., Hou, N., Wang, Y., Wang, Z., Yang, T., Gu, Y., He, M., Shi, Y., Chen, J. et al. (2018) Alteration of the Retinoid Acid-CBP Signaling Pathway in Neural Crest Induction Contributes to Enteric Nervous System Disorder. Front Pediatr, 6, 382. 85 Barlow, A.J., Dixon, J., Dixon, M.J. and Trainor, P.A. (2012) Balancing neural crest cell intrinsic processes with those of the microenvironment in Tcof1 haploinsufficient mice enables complete enteric nervous system formation. Human Molecular Genetics, 21, 1782-1793. 86 Wallace, A.S., Tan, M.X., Schachner, M. and Anderson, R.B. (2011) L1cam acts as a modifier gene for members of the endothelin signalling pathway during enteric nervous system development. Neurogastroenterology & Motility, 23, e510-e522. 87 Solari, V., Ennis, S., Yoneda, A., Wong, L., Messineo, A., Hollwarth, M.E., Green, A. and Puri, P. (2003) Mutation analysis of the RET gene in total intestinal aganglionosis by wave DNA fragment analysis system. J Pediatr Surg, 38, 497-501. 88 Tilghman, J.M., Ling, A.Y., Turner, T.N., Sosa, M.X., Krumm, N., Chatterjee, S., Kapoor, A., Coe, B.P., Nguyen, K.H., Gupta, N. et al. (2019) Molecular Genetic Anatomy and Risk Profile of Hirschsprung's Disease. N Engl J Med, 380, 1421-1432. .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint 89 Moore, M.W., Klein, R.D., Farinas, I., Sauer, H., Armanini, M., Phillips, H., Reichardt, L.F., Ryan, A.M., Carver-Moore, K. and Rosenthal, A. (1996) Renal and neuronal abnormalities in mice lacking GDNF. Nature, 382, 76-79. 90 Pichel, J.G., Shen, L., Sheng, H.Z., Granholm, A.C., Drago, J., Grinberg, A., Lee, E.J., Huang, S.P., Saarma, M., Hoffer, B.J. et al. (1996) GDNF is required for kidney development and enteric innervation. Cold Spring Harb Symp Quant Biol, 61, 445-457. 91 Sanchez, M.P., Silos-Santiago, I., Frisen, J., He, B., Lira, S.A. and Barbacid, M. (1996) Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature, 382, 70-73. 92 Angrisano, T., Sacchetti, S., Natale, F., Cerrato, A., Pero, R., Keller, S., Peluso, S., Perillo, B., Avvedimento, V.E., Fusco, A. et al. (2011) Chromatin and DNA methylation dynamics during retinoic acid-induced RET gene transcriptional activation in neuroblastoma cells. Nucleic Acids Res, 39, 1993- 2006. 93 Thang, S.H., Kobayashi, M. and Matsuoka, I. (2000) Regulation of glial cell line-derived neurotrophic factor responsiveness in developing rat sympathetic neurons by retinoic acid and bone morphogenetic protein-2. The Journal of neuroscience : the official journal of the Society for Neuroscience, 20, 2917-2925. 94 McKeown, S.J., Mohsenipour, M., Bergner, A.J., Young, H.M. and Stamp, L.A. (2017) Exposure to GDNF Enhances the Ability of Enteric Neural Progenitors to Generate an Enteric Nervous System. Stem cell reports, 8, 476-488. 95 Cerchia, L., D'Alessio, A., Amabile, G., Duconge, F., Pestourie, C., Tavitian, B., Libri, D. and de Franciscis, V. (2006) An autocrine loop involving ret and glial cell-derived neurotrophic factor mediates retinoic acid-induced neuroblastoma cell differentiation. Molecular cancer research : MCR, 4, 481-488. 96 Frith, T.J.R., Gogolou, A., Hackland, J.O.S., Hewitt, Z.A., Moore, H.D., Barbaric, I., Thapar, N., Burns, A.J., Andrews, P.W., Tsakiridis, A. et al. (2020) Retinoic Acid Accelerates the Specification of Enteric Neural Progenitors from In-Vitro-Derived Neural Crest. Stem cell reports, 15, 557-565. 97 Lang, D., Chen, F., Milewski, R., Li, J., Lu, M.M. and Epstein, J.A. (2000) Pax3 is required for enteric ganglia formation and functions with Sox10 to modulate expression of c-ret. The Journal of Clinical Investigation, 106, 963-971. 98 Lang, D. and Epstein, J.A. (2003) Sox10 and Pax3 physically interact to mediate activation of a conserved c-RET enhancer. Hum Mol Genet, 12, 937-945. 99 Kapur, R.P. (1999) Early death of neural crest cells is responsible for total enteric aganglionosis in Sox10(Dom)/Sox10(Dom) mouse embryos. Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society, 2, 559-569. 100 Bondurand, N. and Southard-Smith, E.M. (2016) Mouse models of Hirschsprung disease and other developmental disorders of the enteric nervous system: Old and new players. Dev Biol, 417, 139- 157. 101 Pingault, V., Bondurand, N., Kuhlbrodt, K., Goerich, D.E., Prehu, M.O., Puliti, A., Herbarth, B., Hermans-Borgmeyer, I., Legius, E., Matthijs, G. et al. (1998) SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat Genet, 18, 171-173. 102 Bondurand, N., Dufour, S. and Pingault, V. (2018) News from the endothelin-3/EDNRB signaling pathway: Role during enteric nervous system development and involvement in neural crest-associated disorders. Dev Biol, 444 Suppl 1, S156-S169. 103 Baynash, A.G., Hosoda, K., Giaid, A., Richardson, J.A., Emoto, N., Hammer, R.E. and Yanagisawa, M. (1994) Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell, 79, 1277-1285. 104 H osoda, K., Hammer, R.E., Richardson, J.A., Baynash, A.G., Cheung, J.C., Giaid, A. and Yanagisawa, M. (1994) Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice. Cell, 79, 1267-1276. .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint 105 Puffenberger, E.G., Hosoda, K., Washington, S.S., Nakao, K., deWit, D., Yanagisawa, M. and Chakravart, A. (1994) A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell, 79, 1257-1266. 106 Amiel, J., Sproat-Emison, E., Garcia-Barcelo, M., Lantieri, F., Burzynski, G., Borrego, S., Pelet, A., Arnold, S., Miao, X., Griseri, P. et al. (2008) Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet, 45, 1-14. 107 Cantrell, V.A., Owens, S.E., Chandler, R.L., Airey, D.C., Bradley, K.M., Smith, J.R. and Southard- Smith, E.M. (2004) Interactions between Sox10 and EdnrB modulate penetrance and severity of aganglionosis in the Sox10Dom mouse model of Hirschsprung disease. Human Molecular Genetics, 13, 2289-2301. 108 Druckenbrod, N.R. and Epstein, M.L. (2009) Age-dependent changes in the gut environment restrict the invasion of the hindgut by enteric neural progenitors. Development, 136, 3195-3203. 109 Alpy, F., Ritie, L., Jaubert, F., Becmeur, F., Mechine-Neuville, A., Lefebvre, O., Arnold, C., Sorokin, L., Kedinger, M. and Simon-Assmann, P. (2005) The expression pattern of laminin isoforms in Hirschsprung disease reveals a distal peripheral nerve differentiation. Hum Pathol, 36, 1055-1065. 110 Parikh, D.H., Tam, P.K., Van Velzen, D. and Edgar, D. (1992) Abnormalities in the distribution of laminin and collagen type IV in Hirschsprung's disease. Gastroenterology, 102, 1236-1241. 111 Heuckeroth, R.O. (2015) Hirschsprung's disease, Down syndrome, and missing heritability: too much collagen slows migration. J Clin Invest, 125, 4323-4326. 112 Okamoto, N., Wada, Y. and Goto, M. (1997) Hydrocephalus and Hirschsprung's disease in a patient with a mutation of L1CAM. Journal of Medical Genetics, 34, 670-671. 113 Hofstra, R., Elfferich, P., Osinga, J., Verlind, E., Fransen, E., Lopez, P., de Die-Smulders, C.E.M., Stolte-Dijkstra, I. and Buys, C. (2002) Hirschsprung disease and L1CAM: is the disturbed sex ratio caused by L1CAM mutations? Journal of Medical Genetics, 39, e11-e11. 114 Matsui, T. (1996) Differential activation of the murine laminin B1 gene promoter by RAR alpha, ROR alpha, and AP-1. Biochem Biophys Res Commun, 220, 405-410. 115 Schmidt, C., Fischer, G., Kadner, H., Genersch, E., Kuhn, K. and Poschl, E. (1993) Differential effects of DNA-binding proteins on bidirectional transcription from the common promoter region of human collagen type IV genes COL4A1 and COL4A2. Biochim Biophys Acta, 1174, 1-10. 116 Axel, D.I., Frigge, A., Dittmann, J., Runge, H., Spyridopoulos, I., Riessen, R., Viebahn, R. and Karsch, K.R. (2001) All-trans retinoic acid regulates proliferation, migration, differentiation, and extracellular matrix turnover of human arterial smooth muscle cells. Cardiovascular research, 49, 851- 862. 117 Aguilar, R.P., Genta, S., Oliveros, L., Anzulovich, A., Gimenez, M.S. and Sanchez, S.S. (2009) Vitamin A deficiency injures liver parenchyma and alters the expression of hepatic extracellular matrix. Journal of applied toxicology : JAT, 29, 214-222. 118 Alvarez-Dolado, M., Gonzalez-Sancho, J.M., Navarro-Yubero, C., Garcia-Fernandez, L.F. and Munoz, A. (1999) Retinoic acid and 1,25-dihydroxyvitamin D3 inhibit tenascin-C expression in rat glioma C6 cells. J Neurosci Res, 58, 293-300. 119 Gao, N., Wang, J., Zhang, Q., Zhou, T., Mu, W., Hou, P., Wang, D., Lv, X. and Li, A. (2020) Aberrant Distributions of Collagen I, III, and IV in Hirschsprung Disease. Journal of pediatric gastroenterology and nutrition, 70, 450-456. 120 Gregersen, H. and Kassab, G. (1996) Biomechanics of the gastrointestinal tract. Neurogastroenterol Motil, 8, 277-297. 121 Shannon, S.R., Moise, A.R. and Trainor, P.A. (2017) New insights and changing paradigms in the regulation of vitamin A metabolism in development. Wiley interdisciplinary reviews. Developmental biology, in press. .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint 122 Wang, S., Yu, J., Jones, J.W., Pierzchalski, K., Kane, M.A., Trainor, P.A., Xavier-Neto, J. and Moise, A.R. (2018) Retinoic acid signaling promotes the cytoskeletal rearrangement of embryonic epicardial cells. Faseb j, 32, 3765-3781. 123 Wang, S., Huang, W., Castillo, H.A., Kane, M.A., Xavier-Neto, J., Trainor, P.A. and Moise, A.R. (2018) Alterations in retinoic acid signaling affect the development of the mouse coronary vasculature. Dev Dyn, 247, 976-991. 124 Beecroft, S.J., Ayala, M., McGillivray, G., Nanda, V., Agolini, E., Novelli, A., Digilio, M.C., Dotta, A., Carrozzo, R., Clayton, J. et al. (2021) Biallelic hypomorphic variants in ALDH1A2 cause a novel lethal human multiple congenital anomaly syndrome encompassing diaphragmatic, pulmonary, and cardiovascular defects. Hum Mutat, 42, 506-519. 125 Aoto, K., Sandell, L.L., Butler Tjaden, N.E., Yuen, K.C., Watt, K., Black, B.L., Durnin, M. and Trainor, P.A. (2015) Mef2c-F10N enhancer driven beta-galactosidase (LacZ) and Cre recombinase mice facilitate analyses of gene function and lineage fate in neural crest cells. Dev Biol, in press. 126 Rossant , J., Zirngibl, R., Cado, D., Shago, M. and Giguère, V. (1991) Expression of a retinoic acid response element-hsplacZ transgene defines specific domains of transcriptional activity during mouse embryogenesis. Genes & Development, 5, 1333-1344. 127 Natarajan, D., Grigoriou, M., Marcos-Gutierrez, C.V., Atkins, C. and Pachnis, V. (1999) Multipotential progenitors of the mammalian enteric nervous system capable of colonising aganglionic bowel in organ culture. Development, 126, 157-168. 128 Pitera, J.E., Smith, V.V., Woolf, A.S. and Milla, P.J. (2001) Embryonic Gut Anomalies in a Mouse Model of Retinoic Acid-induced caudal Regression Syndrome. American Journal of Pathology, 159, 2321- 2329. 129 Nagy A, G.M., Vintersten K, Behringer RR (2003) Manipulating the mouse embryo. Cold Spring Harbor: Cold Spring Harbor Laboratory, in press. 130 Hama, H., Kurokawa, H., Kawano, H., Ando, R., Shimogori, T., Noda, H., Fukami, K., Sakaue- Sawano, A. and Miyawaki, A. (2011) Scale: a chemical approach for fluorescence imaging and reconstruction of transparent mouse brain. Nat Neurosci, 14, 1481-1488. 131 Kuwajima, T., Sitko, A.A., Bhansali, P., Jurgens, C., Guido, W. and Mason, C. (2013) ClearT: a detergent- and solvent-free clearing method for neuronal and non-neuronal tissue. Development, 140, 1364-1368. 132 Shannon, S.R., Yu, J., Defnet, A.E., Bongfeldt, D., Moise, A.R., Kane, M.A. and Trainor, P.A. (2020) Identifying vitamin A signaling by visualizing gene and protein activity, and by quantification of vitamin A metabolites. Methods Enzymol, 637, 367-418. 133 Robinson, M.D., McCarthy, D.J. and Smyth, G.K. (2010) edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics (Oxford, England), 26, 139-140. 134 Huang da, W., Sherman, B.T. and Lempicki, R.A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc, 4, 44-57. 135 Huang da, W., Sherman, B.T. and Lempicki, R.A. (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res, 37, 1-13. 136 Chen, J., Bardes, E.E., Aronow, B.J. and Jegga, A.G. (2009) ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res, 37, W305-311. 137 Chen, J., Aronow, B.J. and Jegga, A.G. (2009) Disease candidate gene identification and prioritization using protein interaction networks. BMC bioinformatics, 10, 73. 138 Shannon, P., Markiel, A., Ozier, O., Baliga, N.S., Wang, J.T., Ramage, D., Amin, N., Schwikowski, B. and Ideker, T. (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res, 13, 2498-2504. .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint 139 Edgar, R., Domrachev, M. and Lash, A.E. (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res, 30, 207-210. 140 Barrett, T., Wilhite, S.E., Ledoux, P., Evangelista, C., Kim, I.F., Tomashevsky, M., Marshall, K.A., Phillippy, K.H., Sherman, P.M., Holko, M. et al. (2013) NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res, 41, D991-995. 141 Dolber, P.C. and Spach, M.S. (1993) Conventional and confocal fluorescence microscopy of collagen fibers in the heart. J Histochem Cytochem, 41, 465-469. 142 Schneider, C.A., Rasband, W.S. and Eliceiri, K.W. (2012) NIH Image to ImageJ: 25 years of image analysis. Nature methods, 9, 671-675. .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint Figures Figure 1. Rdh10trex is a model for Hirschsprung Disease. TUJ1 (red) and DAPI (blue) immunostaining in E10.5 whole embryos (A,C) and E11.5 whole guts (B,D). (A,C) Mature neurons are labeled with TUJ throughout the head and trunk of Rdh10trex/trex mutant and control littermates. White arrows (A) denote the developing enteric nervous system. Arrows in the mutant embryo (C) indicate intestinal aganglionosis with the absence of enteric neurons. (B) Mature neurons in the E11.5 control gut are present in the stomach and midgut extending to the cecum. (D) The mutant gut shows complete neuronal agenesis with a lack of discernable staining in the stomach, midgut and hindgut. (E-L) Spatiotemporal expression of Rdh10 during normal embryogenesis between E8.5-10.5 shown by LacZ staining of the Rdh10βgeo mouse line. At E8.5, lateral (E) and ventral (F) views of the whole embryo as well as transverse (I) and sagittal (L) sections show Rdh10 expression in the anterior somites, lateral mesoderm and in the mesenchyme surrounding the primitive gut. At E9.5, views of the lateral whole embryo (G) and transverse section (J) show Rdh10 expression in the somites, ventral mesoderm, and anterior foregut diverticulum mesenchyme. At E10.5, views of the lateral embryo (H) and transverse section (K) show Rdh10 expression in the somites, ventral mesoderm, and anterior foregut. Rdh10 mRNA expression by in situ hybridization is seen in a lateral view of the whole embryo (M) and transverse section (N) within the somites, ventral mesoderm and anterior foregut mesenchyme. Scale bars are 500μm. (s) stomach; (m) midgut; (h) hindgut; (nt) neural tube; (da) dorsal aorta; (fg) foregut; (s) somite. .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint Figure 2. Vagal neural crest cell migration is disrupted in Rdh10trex/trex mutant embryos. (A-L) LacZ staining of the F10N mouse line bred into the Rdh10trex/trex background label migrating NCC in blue indicated by the white arrowheads (B,E,H,K). At E9.5, lateral view of control whole embryos (A,B) and transverse section (C) reveal staining of a vagal NCC migrating ventrally into the foregut mesenchyme. At E10.5, lateral view of control whole embryos (G,H) and transverse section (I) similarly show NCC migration into the foregut mesenchyme and midgut region. In contrast, at E9.5 Rdh10trex/trex embryos (D,E) reveal initial vagal NCC migration, and transverse section (F) shows absent neural crest cell staining in the foregut mesenchyme. Similarly, at E10.5, Rdh10trex/trex mutant embryos (J,K) reveal ventrally migrating NCCs, but transverse section (L) indicate a lack of NCC in the foregut mesenchyme. (M-P’) LacZ staining of the Wnt1- cre;R26R mouse line bred into the background of Rdh10trex/trex label pre-migratory NCC and their descendants in blue. (M’-P’) Black arrows indicate the migrating vagal NCC stream in control and Rdh10trex/trex whole embryos. At E9.5, lateral view of control whole embryo (M,M’) reveals expected vagal NCC staining extending into the foregut. At E10.5, a lateral view of control whole embryo (O,O’) similarly shows staining of the vagal NCC stream extending from the foregut into the midgut region. In contrast, whole Rdh10trex/trex embryos lack a vagal NCC stream entirely at both E9.5 (N,N’) and E10.5 (P,P’). (nt) neural tube; (da) dorsal aorta; (fg) foregut. .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint Figure 3. Rdh10trex/trex is retinoid signaling deficient. (A-D) The RARE-lacZ allele was bred into the

Background

of Rdh10trex/trex embryos to visualize active RA signaling in blue via LacZ staining. At E9.5, (A) staining for RA signaling is present in the forebrain and hindbrain/spinal cord junction extending to the tail in control embryos. Rdh10trex/trex (C) shows greatly reduced signaling with staining restricted to the ventral neural tube. (B,D) Whole guts harvested from control and Rdh10trex/trex embryos at E12.5. (B) Control gastrointestinal tract shows broad LacZ staining for RA signaling in the stomach and intestine extending to the cecum. (D) Rdh10trex/trex gastrointestinal tract displays diminished LacZ staining in the stomach with nearly absent staining in the intestine. .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint Figure 4. Rdh10-mediated RA signaling is required for early gut colonization. Retinal in utero gavage of pregnant Rdh10trex/+ dams was used to rescue intestinal aganglionosis. (A-F) TUJ1 (red) and DAPI (blue) immunostaining in whole guts harvested at E11.5. (A,D) Non-gavaged control and mutant embryonic guts. Neurons are present in the control gut (A) in the stomach and midgut leading to the cecum. The mutant (D) lacks discernable neuronal staining entirely in the stomach, midgut and hindgut regions. (B,E) Pregnant dams were gavaged with retinal once daily between E7.5-11.5 with white arrows indicating the caudal most point of enteric neural development. The control whole gut (B) shows normal development with enteric neurons in the stomach and midgut leading to the cecum. Rdh10trex/trex gut (E) has neurons present in the stomach and the first third of the midgut. (C,F) Pregnant dams were gavaged with retinal twice daily between E7.5-9.5, which represents the minimal retinal treatment necessary to rescue the Rdh10trex/trex gut wavefront (C) to a comparable wild-type location (F) indicated by white arrows. (G-R) Temporal Rdh10 deletion in Rdh10fx/fx; ERT2Cre by tamoxifen and progesterone gavage in utero at E6.5 (J-L), E7.5 (M-O) and E10.5 (P-R). Whole guts were harvested at E15.5 with TUJ1 (red) and DAPI (blue) immunostaining. Control littermates at each of these time points are represented by the Rdh10fx/+ embryos given tamoxifen and progesterone gavage at E10.5 (G-I). Guts from embryos treated after E8.5 (P-R) appear indistinguishable from controls with full colonization and neural reticulation through the full gut. Tamoxifen treatment at E7.5 produces neural development in the duodenum (M) and cecum (N) with aganglionosis in the distal most portion of the colon (O), whereas treatment one day earlier at E6.5 results in aganglionosis in the duodenum (J), cecum (K) and colon (L). .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint Figure 5. RET-GDNF-GFRA1 signaling axis signaling is disrupted in Rdh10trex/trex . A. qRT-PCR

Results

show that Rdh10trex/trex embryos have a significantly reduced level of Gdnf, Ret and Gfrα1 compared to control embryos. Relative quantities of each gene are graphed with 95% confidence intervals. Each of these three genes expression level differences showed significant p-values (p<0.05), as indicated by asterisk. Gdnf p=0.0168, Ret p=1.93E-6, Gfrα1 p= 0.0011. B-E. In situ hybridization was used to assess Ret and Gdnf expression domains. B, B’. E9.5 Control embryos express Ret in the foregut and mid-gut shown by the black arrowhead. C, C’. Rdh10trex/trex embryos completely lack Ret-positive staining within the gut. D, D’, F, F’. Control E9.25 and E9.5 embryos express Gdnf within the foregut entrance indicated by the white arrows. E, E’, G, G’. Rdh10trex/trex embryos, however, have a significant downregulation of Gdnf within the foregut shown by the white arrow. H, H’, I, I’. Sections of E9.5 control embryos of foregut mesenchyme and epithelium with more Gdnf signal present in control than Rdh10trex/trex, consistent with the qRT-PCR results (A). .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint Figure 6. RNA sequencing revealed numerous ECM pathway targets. A. MA plot for RNA sequencing. Genes with p-values less than 0.01 and a fold change greater than 1.74-fold are highlighted in red (upregulated in Rdh10trex/trex) or green (downregulated in Rdh10trex/trex). B. The top up and down regulated genes that changed by at least 1.74-fold with a p-value < 0.05 were examined for enrichment of gene ontology (GO) terms. This identified enrichment in several biological processes related to cellular responses to oxygen levels, decreased oxygen levels and hypoxia. Cellular processes related to interstitial and extracellular matrices, and Molecular functions related to fibronectin binding. C. Signaling Pathway Impact Analysis (SPIA) algorithm was used to assess Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway perturbations of all genes with adjusted p-value < 0.05. .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint Figure 7. ENS protein expression of Phox2b and ENS network regulated by Rdh10- mediated RA signaling. A-F. E9.5 embryos co-stained for Phox2b and Sox10. Phox2b stains enteric precursor cells, and Sox10 marks differentiated neurons. A-C Control embryos stained for Phox2b, Sox10 and Merge. D-F Rdh10trex/trex. G. The ratio of NCC to neurons is significantly decreased in Rdh10trex/trex. H. RNA sequencing identified a series of genes that are dysregulated in Rdh10trex/trex that have critical roles in ENS formation and HSCR pathogenesis. The interaction between these genes were mapped by Cytoscape to show gene interactions that include, interactions with Ret (red lines), predicated interactions between genes (yellow lines) and genes in literature that are either co-expressed or co-localize (blue lines). .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint Figure 8. Increased collagen in E9.5 Rdh10trex/trex compared to control embryos. Sirius red staining and fluorescent intensity show in control embryos (A, B, B’). Rdh10trex/trex embryos (C, D, D’). Inset B’ and D’ is quantified in I, J and compared in K. Significant (P<0.05) increase in collagen as measured by Sirius red fluorescent intensity in Rdh10trex/trex. Collagen VI staining for E 9.5 Control (E, G) versus Rdh10trex/trex (F, H). Collagen VI immunostaining appeared increased in Rdh10trex/trex , but was not statistically significant when quantified as flurorescent intesity (Figure 8 L). M. qRT-PCR of Collagen 1a1 and 1a2 significantly increased in Rdh10trex/trex. P<0.05. .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint Figure 9. Proposed model of pathogenesis in Rdh10trex/trex. The point mutation in Rdh10reduces RA signaling, which restricts vagal neural crest cell migration into the foregut. Migration is disrupted by both a decrease in signaling from genes in an ENS signaling network, including Ret, Gdnf and Gfra1, and by an altered ECM composition, specifically increases collagen. Together, these changes limit access of migrating vagal neural crest cells into the foregut leading to incomplete gut colonization and total intestinal aganglionosis. .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted January 23, 2025. ; https://doi.org/10.1101/2025.01.23.634504doi: bioRxiv preprint

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-pdf

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-26T02:00:01.498150+00:00
License: CC-BY-NC-ND-4.0